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ABSTRACT 
Trauma exposure is associated with an increased risk for posttraumatic stress 
disorder (PTSD), which is associated with high long-term stress and severe 
impairment of everyday functioning. Although exposure-based psychotherapy is 
effective, the treatment typically has a high dropout rate, and many patients still 
suffer from PTSD after treatment. Thus, there is a high need for optimizing PTSD 
treatment. Cortisol, a glucocorticoid, has been shown to modulate memory 
processes: cortisol facilitates memory consolidation but inhibits memory retrieval of 
previously learned emotional material. Hence, cortisol has been put forward as a 
pharmacological option to boost PTSD treatment in two ways: continuous cortisol 
administration has been proposed to inhibit intrusive memories based on the 
cortisol inhibition effect and combining single cortisol administrations with 
exposure therapy should enhance therapy outcome for PTSD patients due to the 
enhancing effect of cortisol on memory consolidation. However, experimental 
studies investigating these two proposed effects of cortisol in the context of PTSD 
research are scarce.  
The first study addressed the question if repeated cortisol administration inhibits 
experimentally induced intrusions and recognition memory in a trauma-film-
paradigm. In a randomized double-blind design, participants were exposed to a 
traumatic film and received either a low dose of cortisol or placebo for three days 
following “trauma exposure”. Contrary to our predictions, the cortisol group did not 
have fewer intrusions than the placebo group, nor did it show diminished 
performance on the recognition test. Our results indicate that solely administering 
cortisol after a traumatic experience cannot reduce intrusive re-experiencing. 
In the second study, we aimed to examine the influence of cortisol administration 
on fear extinction. Fear extinction is thought to be one of the memory processes 
underlying exposure therapy. In a randomized double-blind design, participants 
completed to a fear-conditioning-paradigm  (acquisition, extinction and 
reinstatement) on three consecutive days, with neutral faces as conditioned stimuli 
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(CS) and traumatic film clips as unconditioned stimuli (US). Immediately after 
extinction, participants received one dose of either cortisol or placebo. Our results 
show a reduction of the return of fear (ROF) during the reinstatement test for US-
expectancy and fear potentiated startle (FPS) in the cortisol group, but not in the 
placebo group. The results of valence ratings point in the same direction, whereas 
we did not find a cortisol treatment effect for skin conductance response (SCR). 
Nevertheless, these results emphasize the enhancing effect of cortisol on memory 
consolidation, in particular on fear extinction, and thus support the idea that 
cortisol might be a useful exposure treatment adjunct. 
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ZUSAMMENFASSUNG 
Nach Erleben eines traumatischen Ereignisses entwickeln viele Betroffene eine 
Posttraumatische Belastungsstörung (PTBS), welche mit einer hohen 
Langzeitbelastung und einer schweren Beeinträchtigung des alltäglichen 
Funktionsniveaus der Betroffenen einhergeht. Die Behandlung der PTBS erfolgt mit 
Expositions-basierten Elementen der Psychotherapie. Trotz dieses evidenzbasierten 
Ansatzes brechen viele die Behandlung vorzeitig ab und ein beachtlicher Teil der 
Betroffenen leidet nach der Behandlung noch unter Symptomen der PTBS. Es 
besteht daher ein hoher Bedarf, die Behandlung der PTBS weiter zu optimieren. 
Cortisol, ein körpereigenes Glucocorticoid, wird dafür in Betracht gezogen. Aus der 
experimentellen Gedächtnisforschung ist bekannt, dass Cortisol Gedächtnisprozesse 
moduliert. Es verbessert die Gedächtniskonsolidierung und hemmt den Abruf von 
zuvor gelerntem emotionalem Material. Auf Grundlage dieser zwei 
Wirkmechanismen wird Cortisol als eine pharmakologische Option zur 
Verbesserung der PTBS-Behandlung diskutiert. Es gibt zwei Ideen über die Wirkung 
des Cortisol im Kontext der PTBS Behandlung: durch eine kontinuierliche Cortisol-
Gabe sollen spontane, sich aufdrängende Erinnerungen gehemmt werden, was auf 
den Inhibitionseffekten des Cortisols beruht. Durch eine Kombination der Cortisol-
Gabe mit Expositionstherapie soll das Therapieergebnis für PTSD-Patienten 
verbessert werden, da es eine verstärkende Wirkung (Cortisol-
Verbesserungseffektes) auf die Konsolidierung hat. Es fehlen allerdings bisher 
experimentelle Studien, die diese beiden Wirkungen in Bezug auf die PTBS 
untersuchen.  
Die erste Studie untersucht im Rahmen eines Trauma-Film-Paradigmas, ob eine 
wiederholte Cortisol-Gabe experimentell induzierte Intrusionen sowie die explizite 
Erinnerung an das „Trauma“  hemmt. In einem randomisiert, doppelblinden Design 
wurden den Probanden Filme mit traumatischem Inhalt präsentiert. Im Anschluss 
erhielten die Probanden entweder an den drei folgenden Tagen nach der "Trauma-
Exposition" eine niedrige Dosis Cortisol oder ein Placebo. Entgegen unserer 
Annahme berichtete die Cortisol-Gruppe nicht weniger Intrusionen als die Placebo-
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Gruppe, noch zeigten sie eine verminderte Erinnerungsleistung bezüglich der 
einzelnen Filmelemente. Unsere Ergebnisse sprechen dafür, dass eine alleinige 
Cortisol-Gabe unmittelbar nach einem traumatischen Erlebnis Intrusionen nicht 
reduzieren kann. 
In der zweiten Studie wurde der Einfluss einer Cortisol-Gabe auf die Konsolidierung 
des Extinktionslernens in einem Konditionierungsexperiment untersucht. Das 
Extinktionslernen stellt einen der relevanten Mechanismen der Expositionstherapie 
dar. In einer randomisierten, doppelblinden Studie durchliefen die Teilnehmer an 
drei aufeinanderfolgenden Tagen ein Furchtkonditionierungs-Paradigma mit 
Akquisition, Extinktion und Reinstatement. Als konditionierte Stimuli (KS) wurden 
neutrale Gesichtern verwendet und als unkonditionierte Stimuli (US) traumatische 
Filmclips. Unmittelbar nach der Extinktion wurden den Probanden entweder eine 
Dosis Cortisol oder ein Placebo verabreicht. In Übereinstimmung mit unserer 
Annahme zeigte die Cortisol-Gruppe im Vergleich zur Placebo-Gruppe eine 
geringere Rückkehr der Angst während des Reinstatements. Dies äußerte sich in der 
Cortisol-Gruppe durch reduzierte US-Erwartungs-Ratings sowie einem verringerten 
Startle-Reflexes. Des Weiteren weisen die Ergebnisse der Valenz-Ratings der KS in 
die gleiche Richtung. Allerdings konnten wir keinen Einfluss bei der Hautleitfähigkeit 
finden. Zusammengefasst weisen die Ergebnisse der zweiten Studie auf die 
verstärkende Wirkung von Cortisol auf die Gedächtniskonsolidierung, insbesondere 
auf die Extinktion, hin. Die Idee, dass Cortisol eine nützliche Begleitbehandlung zur 
Expositionstherapie sein könnte, wird somit gestützt. 
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I GENERAL INTRODUCTION 
Traumatic experiences are relatively common. About one third of the general 
population of Germany may experience a traumatic event at some point in their 
lives (Hapke et al., 2005; Maercker, Forstmeier, Wagner, Glaesmer, & Brähler, 2008; 
Perkonigg, Kessler, Storz, & Wittchen, 2000). In the United States up to one in five 
people may experience a traumatic event during their lifetime (Breslau, Davis, 
Andreski, & Peterson, 1991; Breslau et al., 1998; Kessler, Sonnega, Bromet, Hughes, 
& Nelson, 1995; Norris, 1992). Traumatic events can be accidents, assaultive 
violence like rape, torture or combat, natural disasters, war or the unexpected loss 
of a loved one (Breslau et al., 1998). In the aftermath of such traumatic experiences, 
people suffer from physiological hyperarousal, heightened nervousness and 
distressing re-experiencing symptoms like intrusive memories or nightmares of the 
traumatic event, emotional numbing and avoidance of the trauma reminders 
(Halligan, Michael, Clark, & Ehlers, 2003; McFarlane, 1988; Shalev, 1992). In most 
people, these symptoms spontaneously regress within a few weeks, but in a 
substantial number of people, these symptoms persist and develop into 
posttraumatic stress disorder (PTSD)1 (Breslau et al., 1991; Kessler et al., 1995; 
Perkonigg et al., 2000). In Germany the lifetime prevalence of PTSD for adults is 
about 2.3% (Maercker et al., 2008) and in the United States it is about 8% (Kessler 
et al., 2005; Kessler et al., 1995), with higher prevalence rates in certain subgroups, 
such as veterans exposed to combat (Hoge, Auchterlonie, & Milliken, 2006). 
Compared to other psychiatric disorders, PTSD is a mental disorder that leads to 
severe impairments in daily life functioning (Norman, Stein, & Davidson, 2007). It is 
associated with high levels of disability and work loss (Alonso et al., 2004), as well as 
with several medical conditions, for example cardiovascular conditions, respiratory 
conditions and metabolic diseases (Sareen et al., 2007). It is thus imperative to 
implement early and successful interventions for PTSD patients. Exposure-based 
therapies are effective interventions to treat PTSD (Cusack et al., 2016), but it is 
                                                     
1
 Note that PTSD is only one possible outcome in the aftermath of a traumatic experience. Other 
disorders, not relevant for this thesis, which can develop after a traumatic life event are major 
depression, anxiety disorders and substance abuse, as well as multiple personality disorders, 
although, these disorders may often occur together with PTSD.  
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ineffective for a number of patients (Schottenbauer, Glass, Arnkoff, Tendick, & 
Gray, 2008): approximately 40% still suffer from PTSD after treatment (Maercker et 
al., 2008; Schottenbauer et al., 2008). Exposure-based therapy is also associated 
with a high dropout rates (Schnurr et al., 2007). So far, no existing intervention is 
ideal, and there is a great need to develop more effective and tolerable treatments 
for PTSD. Therefore, a top priority of PTSD research is to improve therapy 
techniques for PTSD. One approach is to focus on interventions targeting intrusive 
memories, because if untreated these intrusive memories remain a lifetime and 
contribute to the persistence of the disorder (Michael, Ehlers, Halligan, & Clark, 
2005). Another approach is to refine the existing, most successful treatment 
strategies, exposure-based therapies, for PTSD. In the recent years, pharmacological 
approaches have become more important as enhancers for treatments. One 
promising pharmaceutical treatment enhancer for PTSD is cortisol (de Quervain, 
2006, 2007). Cortisol is a glucocorticoid, which has been implicated in the 
modulation of memories (Het, Ramlow, & Wolf, 2005), and several studies have 
already demonstrated beneficial effects of cortisol on PTSD symptoms (Aerni et al., 
2004; de Quervain, 2006, 2007; Schelling, 2002; Schelling et al., 1999; Yehuda et al., 
2015). These beneficial effects may be explained by the dual impact of cortisol on 
memory processes. On the one hand cortisol inhibits retrieval of the traumatic 
memory, which leads to a weakening of the initial trauma memory trace and a new 
non-traumatic experience (extinction learning) can be stored as extinction memory 
(Bentz, Michael, Dominique, & Wilhelm, 2010; de Quervain, Aerni, Schelling, & 
Roozendaal, 2009a). And on the other hand, cortisol may facilitates these long-term 
consolidations of the new extinction memory trace (Bentz et al., 2010; de Quervain 
et al., 2009a). However, to date there are no controlled experimental studies which 
would allow conclusions to be made about the underlying memory mechanism 
responsible for the beneficial effects of cortisol. 
The aim of this doctoral thesis is to address this issue by examining the influence of 
cortisol administration in experimental analog studies on retrieval processes, in 
particular on intrusive memories, and on consolidation of extinction learning, which 
serves as a model for exposure-based therapy (Lonsdorf et al., 2017; Michael & 
Ehlers, 2008). 
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The following chapters address the theoretical background of the two studies. To 
start, two case reports of PTSD are presented, followed by a brief overview of the 
characteristics of PTSD and an overview of relevant memory processes in general as 
well as specifically in PTSD patients. A summary of the most relevant treatments for 
PTSD is then presented, with a focus on new pharmacological approaches, in 
particular on the use of glucocorticoids. This chapter includes a brief overview of 
the studies already addressing the beneficial cortisol effects to date. Subsequently, 
the paradigms used in the two studies are described and the research objectives of 
the doctoral thesis are presented. These will be further elaborated in chapters II and 
III, which contain the original manuscripts of study 1 and study 2 of the present 
doctoral project. Finally, the results of both studies will be summarized, embedded 
in the current literature, discussed regarding their clinical implications and from a 
broader perspective. 
1. POSTTRAUMATIC STRESS DISORDER AND MEMORY PROCESSES 
1.1 Case reports – two stories of PTSD  
“Maria was only 15 when she was attacked by a group of men on the way 
home from school. They took turns screaming abuse at her and then they each 
raped her. Finally, they tried to stab her to death and would almost certainly have 
succeeded had the police not arrived on the scene. For months after this horrifying 
event, Maria was not herself. She was unable to keep the memories of the attack 
out of her mind. At night she would have terrible dreams of rape, and would wake 
up screaming. She had difficulty walking back from school because the route took 
her past the site of the attack, so she would have to go the long way home. She felt 
as though her emotions were numbed, and as though she had no real future. At 
home she was anxious, tense, and easily startled. She felt “dirty” and somehow 
shamed by the event, and she resolved not to tell close friends about the event, in 
case they too rejected her.”   
(Sexual assault victim) 
“Joe saw a good deal of active combat during his time in the military. Some 
incidents in particular had never left his mind – like the horrifying sight of Gary, a 
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close comrade and friend, being blown-up by a land-mine. Even when he returned to 
civilian life, these images haunted him. Scenes from battle would run repeatedly 
through his mind and disrupt his focus on work. Filing up at the gas station, for 
example, the smell of diesel immediately rekindled certain horrific memories. At 
other times, he had difficulty remembering the past — as if some events were too 
painful to allow back in his mind. He found himself avoiding socializing with old 
military buddies, as this would inevitably trigger a new round of memories. His 
girlfriend complained that he was always pent-up and irritable – as if he were on 
guard, and Joe noticed that at night he had difficulty relaxing and falling asleep. 
When he heard loud noises, such as a truck back-firing he literally jumped, as if he 
were readying himself for combat.”  
(Combat veteran) 
(Cohen, H., 2016, originally published on PsychCentral.com on 17 May 2016. from 
https://psychcentral.com/lib/two-stories-of-ptsd/) 
Both Marie and Joe have PTSD. The two case reports serve to illustrate the 
characteristics and symptoms of the disorder described in more detail in the 
following chapters. 
1.2 Posttraumatic stress disorder 
According to the current version of the Diagnostic and Statistical Manual of mental 
disorders (5th ed.; DSM-5; American Psychiatric Association, 2013), PTSD belongs to 
the trauma- and stress-related disorders. It is the result of exposure to actual or 
imminent death, serious injury or sexual violence either by direct experience or by 
personal witnessing or experience in relation to a close person (criterion A). 
Affected individuals suffer from re-experiencing symptoms (criterion B) like 
intrusive memories and/or nightmares of the traumatic event, persistent avoidance 
of trauma related stimuli (criterion C), negative alterations in cognitions and mood 
(criterion D), which are inter alia characterized by an inability to recall main features 
of the trauma and trauma-related alterations in arousal and reactivity (criterion E), 
including hypervigilance, exaggerated startle response and sleep disturbance. These 
symptoms must persist for more than one month (criterion F), and individuals 
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should report a considerable symptom related impairment in everyday functioning 
(criterion G) to diagnose PTSD (American Psychiatry Association, 2000, 2013, 2016). 
Relevant features regarding memory processes in PTSD patients are alterations in 
memory functioning and typically two types of memory disturbances have been 
identified (Elzinga & Bremner, 2002). On the one hand patients show unintentional 
re-experiencing symptoms, like distressing intrusive memories of the traumatic 
event and on the other hand the intentional recall is characterized by confusion 
about the temporal order and the inability to access important details of the trauma 
(Ehlers, Hackmann, & Michael, 2004; Elzinga & Bremner, 2002). 
For a better understanding of the memory mechanism involved in PTSD and in its 
treatment, it is necessary to first look at models of human memory in general. 
1.3 Human memory in general 
Memory processes are generally subdivided into the three sub-processes of 
encoding, consolidation and retrieval. Encoding describes the process whereby 
information is perceived and initially acquired, whereas consolidation is the process 
by which these recently acquired memories are stabilized and transferred into long-
term memory (Dudai, 2004). Memory consolidation is time-dependent and divided 
into two phases: (A) synaptic consolidation, which occurs in the first minutes to 
hours after learning and relies on protein synthesis and (B) system consolidation 
taking days, hours or even years to be accomplished, during which the memory 
becomes independent of the hippocampus (Dudai, 2004). In recent years, another 
process has become the focus of consolidation research: When consolidated fear 
memory is reactivated it returns to a labile state for a short window of time and 
requires protein synthesis to be stored again, i.e., reconsolidation (Dudai, 2004). 
Finally, retrieval, describes the recall of stored information or memories (Baddeley, 
1997). 
It is well known that memory is composed of multiple distinct systems, that operate 
in-/dependently to produce the adaptive and flexible behaviour and reactions of an 
individual in everyday life (Squire, 2004). It is subdivided into declarative (explicit) 
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and nondeclarative (implicit) memory systems (Squire, 2004) (for an overview, see 
Figure 1). 
The former is responsible for a conscious recollection, whereas the latter involves 
all learning processes and memory abilities that have the capacity to acquire 
information implicitly (Squire & Zola-Morgan, 1988; Squire & Zola, 1996). 
Declarative memory is further subdivided into semantic memory, which contains 
factual knowledge (e.g., names, words, functions of objects) and episodic memory, 
which includes the ability to retrieve personally experienced events (e.g., contextual 
knowledge like places and associated emotions) and allows a self-awareness of 
experiences in subjective space and time, also named autonoetic awareness 
(Tulving, 1993). Declarative memories are representational and provide the 
individual with a model of the external world, thus making it possible to judge 
memories about true or false and to compare remembered materials (Squire, 
2004). They are encoded within the medial temporal lobe, comprising 
hippocampus, amygdala, entorhinal cortex and perirhinal cortex, but are 
consolidated and stored in the temporal cortex and elsewhere (Baddeley, 1997). 
Nondeclarative memory contains procedural skills and habits (e.g., knowing how to 
drive a car), priming and perceptual learning (e.g., exposure to a stimulus influences 
response to a later stimulus), simple classical conditioning (e.g., learning a new 
behaviour based on associative learning: two stimuli are linked together to elicit a 
new learned response; e.g., emotional responses and skeletal responses) and 
nonassociative learning (repeated exposure leads to a change in the response; e.g., 
habituation and sensitization). Nondeclarative memories are dispositional and 
exposed through performance rather than recollection (Squire, 2004; Squire & Zola, 
1996). In contrast to declarative memories, nondeclarative memories cannot be 
judged as true or false. The brain areas mediating these memory functions are quite 
heterogeneous: in procedural memory, the striatum is thought to be involved, while 
priming is mediated by areas of the neocortex. The amygdala plays a central role in 
emotional learning in classical conditioning, while the cerebellum is the basis of 
skeletal responses and nonassociative learning is based on neural reflex pathways 
(Squire, 2004). 
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Figure 1. Taxonomy of long-term memory systems, containing the different memory systems and 
their relevant brain structures (adapted from Squire, 2004) 
In the manifestation of PTSD memory disturbances are predominant as patients 
suffer from intrusive memories of the traumatic event and show an inability to 
recall important aspects of the trauma (American Psychiatry Association, 2000, 
2016). Additionally, maladaptive learning processes during and after the trauma are 
assumed to contribute to the manifestation of PTSD. These different processes will 
be described in more detail in the next chapters. 
1.4 Intrusive memories in PTSD 
Intrusive memories are considered a cardinal symptom of PTSD (Ehlers et al., 2004) 
although, they may also occur in healthy individuals and in association with other 
mental disorders as well (Brewin, Gregory, Lipton, & Burgess, 2010; Pfaltz, Michael, 
Meyer, & Wilhelm, 2013). However, clinically relevant intrusions – compared to the 
daily life intrusions of healthy individuals – can be identified by their extreme 
distress, content and frequency (Brewin et al., 2010). In the older PTSD literature 
intrusive memories were described as intrusive thoughts, but nowadays research 
suggests that intrusive memories mainly consist of spontaneous and uncontrollable 
brief sensory fragments of the traumatic event, in the form of visual images, 
sounds, smells, tastes or bodily sensation such as pain (Ehlers et al., 2004; Michael 
et al., 2005). Intrusive memories are associated with a high level of emotional 
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distress and can be triggered by a wide range of internal and external cues (Brewin, 
2001; Brewin et al., 2010) of which patients usually are unaware of. This leads to 
the feeling that intrusive memories pop up out of the blue (Michael et al., 2005) and 
are uncontrollable. Regarding to the two case reports at the beginning the trigger in 
Marias case was the way home or seeing a group of men and in Joe´s case a gas 
station and the smell of diesel. Triggers of intrusive memories often do not have a 
meaningful relationship to the trauma; rather, they match the sensory 
characteristics of stimuli that were present previous to or during the time of the 
trauma (Ehlers & Clark, 2000; Ehlers et al., 2004). Furthermore, intrusive memories 
most commonly do not reflect the most burdening aspect of the trauma but instead 
the aspects temporally associated with the trauma. Thus, the content of the 
intrusive memory could be seeing the gas station located next to the place where 
the comrade of Joe was being blown-up by a land-mine or seeing men coming 
towards her in the case of Maria. Both the trigger and the intrusion itself could be 
interpreted as “warning signals” that let the individual know something bad is going 
to happen (Ehlers et al., 2004). Several authors observed that intrusive memories 
are attended by a sense of “nowness” (e.g., Brewin, Dalgleish, & Joseph, 1996; 
Ehlers & Clark, 2000; Ehlers et al., 2004), meaning that these memories lack the 
awareness that they are something from the past, and are instead experienced as 
some kind of threat in the present (Ehlers & Clark, 2000; Ehlers et al., 2004; 
Hackmann, Ehlers, Speckens, & Clark, 2004). As a result, intrusions generate 
psychological and physical responses, for example increased heartbeat, attack of 
sweating, tension and muscular contraction, comparable to those observed during 
the trauma (Michael et al., 2005), and are possibly experienced as a re-enactment 
of the original trauma. Afterwards, these psychological and physical responses lead 
to further symptoms that are described in the case reports (e.g., Joe had difficulty 
relaxing and falling asleep, and Maria was anxious, tense and easily startled). 
Moreover, patients with intrusive memories show an inability to access relevant 
context information that would allow an updating or correction of the trauma 
memory (e.g., Joe had difficulty remembering the past — as if some events were 
too painful to allow back into his mind) (Ehlers & Clark, 2000; Ehlers et al., 2004; 
Michael et al., 2005). The failure to access the information, “I survived the attack”, 
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during an intrusive memory after seeing a trigger will elicit a sense of real and 
current threat, such as, “I will die”. 
The lack of autonoetic awareness indicates that intrusive memories differ from 
normal autobiographical memory (Brewin et al., 1996; Ehlers & Clark, 2000; Ehlers 
et al., 2004), which involves the episodic memory system of declarative (explicit) 
memory (Koriat, Goldsmith, & Pansky, 2000; Tulving, 1993). Thus, other memory 
processes are assumed to be involved in the formation and maintenance of 
intrusive memories. 
For instance, the emotional-processing theory of PTSD which centres on the 
formation of so called fear networks in long term memory. These fear network 
model proposes that traumatic memories are stored in particularly large fear 
networks (Foa & Kozak, 1986). Fear networks distinguish between “hot” and “cold” 
memories, where the former comprises sensory, emotional, cognitive, and 
interoceptive memories of an event and the latter represents autobiographical 
context information. In healthy individuals, “hot” and “cold” memory elements are 
well-integrated, but in PTSD patients, they are perceived as dissociated. This 
possibly leads to automatic activation of both memory elements including the 
trauma related fear network if a stimulus (i.e., trigger of the trauma) matches the 
emotional memory network and may result in re-experiencing symptoms and 
intense fear reactions (Wilker, Elbert, & Kolassa, 2014). 
Another postulated explanation is the dual representation theory, which 
distinguishes between two different levels of processing of the traumatic event: 
conscious and nonconscious. The conscious process consists of abstract, context-
bound representations mediated by the hippocampus and surrounding medial 
temporal lobe structures, whereas the nonconscious process reflects low-level, 
sensory-based representations primarily mediated by the amygdala and insula 
(Wilker et al., 2014). In PTSD, the different levels of processing are associated with 
simultaneous impaired hippocampal function and intensified amygdala function 
(Brewin et al., 1996; Brewin, 2001; Brewin et al., 2010). Hence, sensory cues can 
activate sensory representations (bottom up) without activating higher contextual 
knowledge and thereby lead to intense fear responses or intrusive memories. 
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Finally, the cognitive model of PTSD identifies several maintenance mechanisms 
serving to prolong distress in PTSD. Re-experiencing symptoms may explained by 
the insufficient and fragmented encoding and integration of the trauma into the 
autobiographical memory system (Ehlers & Clark, 2000; Ehlers et al., 2004). 
Increased perceptual priming and associative learning, which are both implicit 
memory mechanisms, are assumed to be responsible for these deficient encoding 
and integration of trauma experiences. Further, beliefs concerning the traumatic 
event, the self, others and the future (e.g., negative alterations in cognitions and 
mood) lead to intense emotional reactions (e.g., hyperarousal) and coping 
strategies (e.g., avoidance) that have maladaptive consequences. Altogether, this 
contributes to the preservation of the disorder and the immense distress patients 
are suffering from. 
The occurrence of intrusions is part of a vicious cycle (see Figure 2): intrusions lead 
to a permanent re/consolidation and strengthening of the trauma memory, which is 
then more easily retrieved in the form of intrusions by trauma cues. The intrusive 
re-experiencing is further re/consolidated and then stored in the trauma memory, 
which contributes to the persistence of the disorder (Bentz et al., 2010; De 
Quervain, Aerni, Schelling, & Roozendaal, 2009b). Therefore, one aim of PTSD 
research is to derive suitable therapeutic methods targeting intrusive memories. 
 
Figure 2. Model of the self-reinforcing circulation of traumatic memories. A persistent retrieval of 
traumatic memories leads to intrusive re-experiencing symptoms typical of PTSD. The resulting 
re/consolidation of these trauma/fear memories reinforces trauma memory and facilitates their 
renewed retrieval (adapted from Bentz et al., 2010)  
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1.5 Associative (fear conditioning) and non-associative memory processes in 
PTSD 
From a conditioning perspective, symptoms of PTSD emerge from maladaptive 
learning processes occurring during and after traumatic experiences and 
manifesting in associative and nonassociative forms (Lissek & Grillon, 2012). In 
general, classical conditioning is a learning process characterized by the acquisition 
of a conditioned response (CR) to an originally neutral stimulus, which becomes a 
conditioned stimulus (CS) by its association with a biologically relevant stimulus, the 
unconditioned stimulus (US) (Pavlov, 1927). In PTSD, associative fear conditioning is 
the learning and expression of a previous conditioned fear (CR) to initially neutral 
stimuli for instances, things, places and people (CS) that are associated with the 
traumatic experience (US). In contrast, nonassociative learning in PTSD is 
characterized by the failure to adapt to intense, novel or fear-related stimuli 
normally seen in habituation or sensitization and reflects a more general 
overreactivity (Lissek & van Meurs, 2015). Initially, these mechanisms are useful for 
both early detection and prevention of a further life threat. If, however, the fear is 
no longer indicative of an existing danger persists, it constitutes to a maladaptive 
expression of fear. These two learning processes, contribute not only to re-
experiencing symptoms, as already indicated in the previous chapter, but also to 
the avoidance symptom clusters (Lissek & van Meurs, 2015). Avoidance is a 
common reaction to a traumatic event and most PTSD patients show emotional 
(e.g., thoughts and feelings about the trauma) and behavioural (e.g., trauma-related 
situations and places) avoidance. However, this interferes with recovery and healing 
because corrective experiences such as “I survived” or “there is no danger 
anymore” are not possible. Thus, exposure to and engagement with the traumatic 
experience is important to make corrective experiences such as “I survived and I am 
safe now”. 
Conditioning models explain posttraumatic psychopathology mainly with a 
resistance to extinguishing the conditioned fear (Lissek & Grillon, 2012). Extinction 
of a previously acquired fear refers to a decline in fear responses (CR) to the 
conditioned stimuli (CS) when repeatedly presented without the aversive 
unconditioned stimuli (US). Importantly, during extinction, a new memory trace is 
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formed that inhibits rather than erases the acquired CS-US association (Bouton, 
2004). In other words, extinction consists of a second learning experience with the 
CS (i.e., the CS as harmless) that competes with the original fear-laden memory 
trace (i.e., the CS as a signal of threat). Two mechanisms have been brought to 
explain the resistance to fear extinction in PTSD in the competition-theory: 1) 
abnormally strong acquisition that overpowers the inhibitory effects of extinction, 
i.e., hyper-conditionability and 2) insufficiently strong extinction (inhibitory) 
learning that confers a competitive edge to the old fear-laden memory (Lissek & 
Grillon, 2012). Thus far, several studies could show an increased acquisition (e.g., 
Orr et al., 2000) as well as insufficiently strong extinction learning in patients with 
PTSD (e.g., Blechert, Michael, Vriends, Margraf, & Wilhelm, 2007), both of which are 
predictive of the severity of PTSD symptoms (Wilker et al., 2014). Even more, there 
is evidence for stimulus overgeneralization and sustained contextual anxiety in 
patients with PTSD (Lissek & Grillon, 2012; Lissek & van Meurs, 2015). 
Nonassociative learning accounts for PTSD presume that traumatic experiences 
impair an individual’s ability to autonomically adapt or habituate to intense, novel 
or fear-relevant environmental stimuli and further induce hyper-excitability (i.e. 
stress sensitization) to those stimuli (Lissek & van Meurs, 2015). Habituation reflects 
autonomic, behavioural or neural responses to stimuli that in healthy individuals 
decrease with repeated stimulation. Patients with PTSD show a failure of 
habituation, indicated by persistent autonomic responding to reappearing and more 
or less irrelevant sensory cues (Lissek & van Meurs, 2015; Pole et al., 2009). This 
failure to habituate is a central contributor to the hyper-arousal cluster of PTSD 
symptoms, and the hyper-excitability is assumed to be the underlying mechanism 
(Lissek & van Meurs, 2015). Hyper-excitability reflects increasing autonomic 
responses to stimuli in the same category as those involved in habituation and 
results in hyper-arousal symptoms such as exaggerated startle, hypervigilance and 
poor concentration (Lissek & Grillon, 2012). These assumptions are supported by 
findings of increased heart rate (e.g., Orr, Solomon, Peri, Pitman, & Shalev, 1997), 
elevated skin conductance responses (for a review, see Pole et al., 2009) and 
accelerated startle responses to some degree in traumatized individuals with PTSD 
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compared to those without (for a review see Grillon & Baas, 2003; Grillon, Morgan, 
Southwick, Davis, & Charney, 1996). 
1.6 Recognition memories in PTSD 
In addition to the mainly implicit memory alterations discussed above, 
impoverished declarative memory functioning has also been reported by PTSD 
patients. Patients show an inability to recall and reflect on certain aspects of the 
traumatic experience, including trauma-related amnesia and 
fragmentation/disorganization of the trauma memory (Elzinga & Bremner, 2002; 
Foa, Molnar, & Cashman, 1995). The inability to reflect on or recall details is 
typically not explained by other factors such as head injuries or substances use 
(American Association, 2000). There are only weak findings to support a complete 
psychogenic amnesia (Evans, Mezey, & Ehlers, 2009), but in some studies a 
substantial number of individuals report that they have long periods with no 
memory of traumatic experiences, especially from their childhood (Scheflin & 
Brown, 1996; Williams, 1994). It is suggested that trauma-related amnesia may 
occur at some point (Elzinga & Bremner, 2002). However, affected individuals 
typically remember most of the event, but have difficulties with the intentional 
recall and report fragmentation of memories (Halligan et al., 2003). 
Apart from the trauma related memory disturbances, fragmentation of memories is 
also found for ordinary autobiographical events in PTSD patients (Elzinga & 
Bremner, 2002). Moreover, a deficit in attention and working memory processes 
(for a meta-analysis, see Scott et al., 2015) and a cognitive bias towards low 
memory specificity for autobiographical events, as well as an overgeneral memory, 
have been found in PTSD patients (e.g., Kleim & Ehlers, 2008; Williams et al., 2007). 
Furthermore, PTSD is associated with deficits in general cognitive functions. Several 
studies report impairments for verbal and visual memory, although the impairment 
is stronger for verbal memory and this association is found in both civilian and 
military samples (for meta-analysis, see Brewin, Kleiner, Vasterling, & Field, 2007; 
Johnsen & Asbjørnsen, 2008). Hippocampal dysfunction, due to chronic or acute 
stress may partly account for these deficits in declarative memory in PTSD (Elzinga 
& Bremner, 2002). 
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To summarize, PTSD patients show an inability to recall important aspects of the 
trauma but suffer from intrusive memories of the traumatic event contributing to a 
constantly re/consolidation of the traumatic experiences. Further, they avoid 
trauma-related emotions and behaviour and they show maladaptive learning 
processes such as the resistance to extinguish previous learned fear. Both processes 
hinder a new corrective experience. Altogether, these processes contribute to the 
maintenance of PTSD and emphasize the severity of the disorder and the need for 
an adequate treatment for individuals with PTSD to help them to recover, to return 
to “normality” and to regain quality of life. Thus, the improvement of treatment 
options should address these different processes. 
2. TREATMENT APPROACHES FOR PTSD 
A variety of psychological and pharmacological treatments are available for PTSD. 
The psychological treatment options are distinguished in trauma-focused 
interventions, which directly address feelings, cognitions and memories of the 
traumatic experience and non-trauma-focused interventions, which aim to help 
patients with the occurring PTSD symptoms without directly targeting trauma-
related memories, feelings or cognitions (Cusack et al., 2016). Trauma-focused 
interventions include cognitive therapy, with its specific types of cognitive 
behavioural therapy (CBT), cognitive processing therapy, cognitive restricting, 
exposure therapy (e.g., prolonged exposure) and eye movement desensitization and 
reprocessing (EMDR). Non-trauma-focused techniques include relaxation training, 
Stress inoculation therapy, assertiveness training, and biofeedback. The current S3 
guidelines of the “Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen 
Fachgesellschaften e.V“ (AWMF), which were developed by the German Society of 
Psychotraumatology (Deutschsprachige Gesellschaft für Psychotraumatologie 
[DeGPT]) in collaboration with other medical specialists, recommend trauma-
focused psychotherapy as the primary treatment choice (Flatten et al., 2011). These 
recommendations are in line with other international guidelines such as the 
National Institutes of Clinical Excellence Guidelines (National Institutes of Clinical 
Excellence [NICE], 2005), the Australian Guidelines (Australia-Centre for 
Posttraumatic Mental Health, 2007) and the Cape Town Consensus Conference on 
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the Treatment of PTSD (Stein et al., 2009). For trauma-focused interventions, 
several studies report moderate to high effect sizes for trauma-focused CBT, CBT-
mixed therapies for PTSD, exposure therapy, and EMDR (Bisson & Andrew, 2005; 
Bradley, Greene, & Russ, 2006; Cusack et al., 2016; Van Etten & Taylor, 1998). Only 
one meta-analysis found a treatment success for stress management in PTSD 
patients, however, it could not be confirmed for any other non-trauma-focused 
interventions (Bisson & Andrew, 2005). Trauma-focused interventions are based on 
principles of learning and conditioning and the emotional processing theory of 
PTSD. The interventions include repeated exposure to traumatic memories and 
trauma-related stimuli in the absence of any danger in order to overcome anxiety 
and/or distress (Foa & Kozak, 1986; Joseph & Gray, 2008). That implies for example 
that a patient is confronted with memories of his/her traumatic experience until 
conditioned responses such as physiological reactions, levels of distress and cue-
driven retrieval of trauma memories are greatly attenuated. Exposure can be 
imaginal in nature or in vivo, although most therapy protocols use a combination of 
both. It is assumed that exposure to the traumatic experience may be one of the 
relevant components underlying the beneficial effects of these trauma focused 
interventions. More specifically, extinction learning, an experimental model of 
exposure therapy, is considered to be one of the major mechanism in trauma-
focused interventions (Lonsdorf et al., 2017; Michael & Ehlers, 2008). 
Although exposure-based therapies are recommended as the first-line treatment 
for PTSD, it is important to note that a substantial number of patients still suffer 
from a relatively high symptom load after treatment. The rate varies between 16-
68% depending on different studies (Schottenbauer et al., 2008) and treatment is 
also associated with high dropout rates (Schnurr et al., 2007). This may reflect 
either the high logistical demands of interventions compared to wait list control or 
that some interventions are simply not suitable for some individuals (Bisson & 
Andrew, 2005). So far data on this issue are scarce. 
With regard to pharmacotherapy, there are indications of the beneficial effects of 
some substances that belong mainly to the group of antidepressants. In particular, 
selective serotonin reuptake inhibitors (SSRIs) showed the largest short- and long-
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term efficacy in the treatment of PTSD. Additional promising initial findings are 
reported for the selective noradrenergic reuptake inhibitor (SNRI) venlafaxine and 
the atypical antipsychotic risperidone (for a review, see Ipser & Stein, 2012). So far, 
there is no evidence for the effectiveness of benzodiazepines, although they are 
regularly used in clinical practice (Ipser & Stein, 2012). Pharmacotherapy is less 
successful than trauma-focused CBT but more successful than a wait list control 
condition (Van Etten & Taylor, 1998). However, pharmacotherapy remains an 
important clinical option and should be considered under certain conditions as 
adjunct or next line treatment, e.g., if a psychological intervention is not possible or 
not effective (American Association, 2015, National Institute for Health and Care 
Excellence, 2005, but see Otto, McHugh, & Kantak, 2010). Pharmacotherapy is often 
useful for treating comorbid mental disorders, e.g., depression and/or other anxiety 
disorders in individual cases (Friedman, Davidson, & Stein, 2009). 
There is still a great need for research in the field of psychopharmacotherapy in 
view of the fact that there is a much greater availability of prescribing clinicians 
than of qualified psychotherapists, and especially with regard to treatment-relevant 
aspects, e.g., the combination of psycho- and pharmacotherapy or the possible use 
of pharmaceuticals for prevention (Friedman, 2007). 
2.1 New treatment approaches: pharmacological enhancers for PTSD treatment  
Increasing preclinical and clinical evidence indicates that specific pharmaceutical 
administered after the traumatic event may prevent the development of PTSD. 
Furthermore, so-called pharmacological enhancers, given as adjuncts to 
psychotherapeutic approaches, showed to improve treatment outcome via 
different mechanisms (for a general review, see Singewald, Schmuckermair, 
Whittle, Holmes, & Ressler, 2015). Recently, these two pharmacological approaches 
have become focus of research. 
Examples for the prevention of PTSD by new pharmacological treatments include 
propranolol and hydrocortisone. Propranolol may have a preventive effect on 
subsequent PTSD development if administered following an acute traumatic event 
(Pitman et al., 2002). Studies administrating hydrocortisone in physically injured 
patients after the traumatic event have shown moderate quality evidence for the 
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prevention of PTSD (e.g., Delahanty et al., 2013; Schelling et al., 2001) and a low 
dose of cortisol administered over the course of one month showed beneficial 
effects on pre-existing PTSD symptoms (e.g., Aerni et al., 2004). 
The so-called pharmacological enhancers include D-cycloserine and hydrocortisone. 
The combination of D-cycloserine with exposure therapy, yields greater 
improvements in PTSD symptoms (e.g., Difede et al., 2014). Last but not least, the 
combination of cortisol with exposure therapy had a positive effect on therapy 
outcome in combat veterans (Yehuda et al., 2015). 
In the following chapter, the focus will be on hydrocortisone, a chemically 
manufactured version of the glucocorticoid cortisol in humans (and corticosterone 
in animals), and its potentially enhancing effects on the treatment of PTSD. 
3. THE GLUCOCORTICOID CORTISOL 
Cortisol is a steroid hormone belonging to the class of glucocorticoids (GCs). It is 
involved in the regulation of metabolism in the cells and helps regulate stress within 
the body (Aguilera, 1994; Karow & Lang-Roth, 2012). The synthesis of cortisol from 
cholesterol occurs in the zona fasciculate of the adrenal cortex within the adrenal 
gland (Aguilera, 1994; Mutschler, Geisslinger, Kroemer, Ruth, & Schäfer–Korting, 
2008) and is regulated by the hypothalamic-pituitary-adrenal (HPA) axis. Key 
elements of the HPA axis are the neuroendocrine neurons in the paraventricular 
nucleus of the hypothalamus that synthesize and promote the secretion of the 
corticotropin-realising hormone (CRH), which in turn stimulates the secretion of 
adrenocorticotropic hormone (ACTH) in the anterior lobe of the pituitary gland. 
ACTH then affects the adrenal cortex, which initiates the synthesis and release of 
GCs, mainly cortisol. In a negative feedback loop, cortisol reacts on the 
hypothalamus and pituitary to suppress the secretion of CRH and ACTH (Aguilera, 
1994) and also influences the hippocampus, the amygdala and the prefrontal cortex 
(PFC) (Wolf, 2008). Indeed, cortisol does not have a constant level, but rather it is 
released in a circadian rhythm with a maximum concentration of 5–23 nmol/l in the 
morning between 6 and 8 a.m., gradually decreasing throughout the day to a 
minimum concentration around midnight (Karow & Lang-Roth, 2012; Mutschler et 
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al., 2008). In addition to the circadian rhythm, cortisol is secreted as a response to 
stress, including physical stress (e.g., excessive exercising, injuries, hyperglycaemia 
and pain) and acute (e.g., fear of an upcoming oral exam) and chronic psychological 
stress (e.g., constant work overload or emotional neglect) (Karow & Lang-Roth, 
2012). Exposure to a stressor increases the release of adrenalin and noradrenalin 
orchestrated by the sympathetic nervous system (SNS) in a first rapid response. In a 
second slower response regulated by the HPA axis, increased CRH secretion initiates 
the secretion of ACTH, and this in turn stimulates cortisol production and increases 
its synthesis rate 10-15 times.  Cortisol concentration reaches its maximum level in 
5 to 30 min and declines to basal levels within the following hours depending on the 
nature and intensity of the stressor (Aguilera, 1994). If the stress becomes 
persistent or GC levels repeatedly remain above basal levels (Aguilera, 1994), it has 
a negative impact on health. Different somatic diseases (e.g., Cushing’s syndrome) 
and psychological disorders such as major depression and PTSD are associated with 
an alteration of HPA axis function (Yehuda, Teicher, Trestman, Levengood, & Siever, 
1996). 
However, initially increased cortisol levels are necessary for the successful adaption 
to different environmental demands that is critical for survival (Aguilera, 1994). The 
freely available GCs in the bloodstream promote the mobilization of stored energy, 
potentiate a number of sympathetically mediated effects, such as peripheral 
vasoconstriction, modulate immune and inflammatory responses and influence 
central nervous system (CNS) processes, such as cognition (Kaiser & Kley, 2002). GCs 
affect the entire body because they are able to cross the blood-brain-barrier and 
bind to mineralocorticoid (MR or Type 1) and glucocorticoid (GR or Type 2) 
receptors in the CNS. These two receptors are homologous in their structure but 
differ in their affinity for GCs. The MR binds cortisol with a tenfold higher affinity 
than the GR and is strongly bound even during low GC secretion, whereas the GR is 
extensively bound only at high levels of GCs, such as during acute stress responses 
(Kaiser & Kley, 2002). Both receptor types are present in the brain in high density in 
the limbic system, especially in the hippocampus and the amygdala, but also in the 
prefrontal cortex (de Kloet, Derijk, & Meijer, 2011). Among the effects of GCs it is 
possible to differentiate between slowly occurring genomic effects influencing gene 
I  G e n e r a l  Introduction  | 19 
 
expression and protein biosynthesis and rapid non-genomic effects that control cell 
membrane stability, where participation of the cell nucleus is not necessary (Karow 
& Lang-Roth, 2012). 
Several studies have shown that GCs can have rapid as well as long-lasting effects 
on the function and structure of the brain (e.g., De Kloet, Joëls, & Holsboer, 2005; 
Herbert et al., 2006). Of particular interest for this thesis is the influence of cortisol 
on cognitive processes, especially its memory modulating effects. 
3.1 The effects of glucocorticoids on memory processes in general 
In numerous animal and human studies, the memory-modulating effect of cortisol 
was observed, both during endogenous elevated cortisol levels due to stress 
exposure (in humans, for example, with the Trier Social Stress Test (TSST) or the 
cold pressure test (CPT)) and after exogenous administration of cortisol 
(hydrocortisone) (for reviews and meta-analysis, see Colciago, Casati, Negri-Cesi, & 
Celotti, 2015; De Quervain et al., 2009b; Het et al., 2005; McIntyre, McGaugh, & 
Williams, 2012; Roozendaal, 2000; Roozendaal, 2003; Sauro, Jorgensen, & Teal 
Pedlow, 2003; van Ast, Cornelisse, Meeter, Joëls, & Kindt, 2013; Wolf, 2008). Most 
of the studies have investigated the effect on declarative memory processes (mostly 
hippocampal-dependent), but there are also studies reporting effects on executive 
functions such as working memory (Luethi, Meier, & Sandi, 2008; Shields, Bonner, & 
Moons, 2015). In addition, it has been shown that cortisol also have an effect on 
implicit memory processes such as conditioning (e.g., Drexler, Hamacher-Dang, & 
Wolf, 2017; Meir Drexler, Merz, Hamacher-Dang, Tegenthoff, & Wolf, 2015; Yang, 
Chao, & Lu, 2006), and priming, (e.g.,  Hidalgo et al., 2012; Holz, Lass-Hennemann, 
Streb, Pfaltz, & Michael, 2014), both of which are memory processes underlying 
intrusive memories. Moreover, as mentioned in the previous chapter, increased 
cortisol levels due to medical conditions such as Cushing Syndrome or depression 
and disturbed cortisol functions in PTSD are associated with memory disturbances 
(Brown, Varghese, & McEwen, 2004; Yehuda et al., 1996). 
Depending on the time of the heightened cortisol concentrations there are different 
effects on memory performance (Het et al., 2005; Roozendaal, 2002). Thus, it is 
necessary to distinguish between learning (acquisition), consolidation processes and 
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retrieval when the modulating effect of cortisol on memory functions is considered. 
Cortisol has been shown to have beneficial effects on learning performance if 
administered or endogenously increased immediately after a learning phase, and 
thus has been used to facilitate consolidation processes (Beckner, Tucker, Delville, 
& Mohr, 2006; Buchanan & Lovallo, 2001), as well as reconsolidation processes 
(Bos, Schuijer, Lodestijn, Beckers, & Kindt, 2014). In contrast, increased cortisol 
concentration before a memory test is associated with poorer performance in 
declarative memory retrieval indicating a retrieval inhibition effect (Ackermann, 
Hartmann, Papassotiropoulos, Dominique, & Rasch, 2013; Buchanan & Tranel, 
2008; de Quervain et al., 2003; Kuhlmann, Kirschbaum, & Wolf, 2005; for a 
metaanalytic review, see Sauro et al., 2003). See Figure 3 for an illustration of the 
effects of cortisol on memory functions. In addition, there is evidence that these 
effects can be extended to autobiographical memory, a subcategory of episodic 
(declarative) memory (Buss, Wolf, Witt, & Hellhammer, 2004). 
 
Figure 3. Effects of stress and glucocorticoids on memory functions. Although glucocorticoids 
enhance memory consolidation, they impair memory retrieval (adapted from Bentz et al., 2010) 
Even though multiple studies found effects of cortisol on memory functions, there 
are some specific characteristics that should be considered. First, it is important to 
note that the effects of cortisol on memory functions follow an inverted U-shaped 
course and thus, these effects are dose-dependent (Rimmele, Meier, Lange, & Born, 
2010; Schilling et al., 2013; but for contrary results, see Rimmele, Besedovsky, 
Lange, & Born, 2015). Second, cortisol effects are found to a greater extent in 
emotional contexts (e.g., Abercrombie, Speck, & Monticelli, 2006; Buchanan & 
Lovallo, 2001; Kuhlmann et al., 2005; Kuhlmann & Wolf, 2006; LaBar & Cabeza, 
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2006), in which arousal seems to be more relevant than valence (Wolf, 2008). Last 
but not least, there is accumulating evidence showing that the effects of cortisol on 
memory processes in general and on memory retrieval differ between men and 
women (Sandi, 2013; Sauro et al., 2003; Wolf, Schommer, Hellhammer, McEwen, & 
Kirschbaum, 2001). Additionally, it has been shown that memory formation also 
differs between free-cycling females and females taking hormonal contraceptives 
(Ferree, Kamat, & Cahill, 2011; Merz et al., 2012), particularly in conditioning 
processes (Wolf, 2008). 
On the basis of various animal studies and imaging studies in humans, these findings 
have been integrated into models attempting to explain, among other things, the 
contrary (both enhancing and inhibiting) effects of cortisol on memory processes. In 
these models a particular role is attributed to the hippocampus since it appears to 
be especially susceptible to the memory-modulating effects of GCs with its key 
function in memory and its particularly high density of glucocorticoid receptors 
(Elzinga & Bremner, 2002; Schwabe & Wolf, 2013). In addition, it is assumed that 
the effects of GCs also depend on the parallel occurring stress-induced 
noradrenergic activity, especially in the basolateral complex of the amygdala (De 
Quervain et al., 2009b; LaBar & Cabeza, 2006; McGaugh & Roozendaal, 2002; 
Roozendaal, McEwen, & Chattarji, 2009), which in turn influences the hippocampus 
and other relevant brain structures such as the prefrontal cortex. Despite, multitude 
of research on the complex interactions of GCs with other hormones, 
neurotransmitters and brain regions, their effects on cognitive performance are not 
yet entirely resolved. 
Altogether, these findings from basic research on the dual effects of cortisol on 
memory processes enabled and initiated the switch to clinical research with the 
goal of reducing PTSD symptoms and improving PTSD therapy. The accumulated 
findings regarding cortisol as pharmacological option to reduce PTSD symptoms and 
as a potential therapy enhancer for PTSD are discussed in the next chapter. 
3.2 Glucocorticoids as potential pharmacological enhancers of PTSD treatment 
Within the framework of cortisol potentially reducing PTSD symptoms and 
optimizing the treatment for PTSD, two accounts have been put forward. 
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First, cortisol might help to inhibit the retrieval of trauma memories, due to 
retrieval impairing effects of glucocorticoids (Bentz et al., 2010; De Quervain et al., 
2009b). The excessive and involuntary retrieval of trauma memories (i.e., intrusions, 
re-experiencing) contributes to the maintenance of the disorder as already 
described in chapter 1.4 (see also Figure 2). By inhibiting this trauma/fear memory 
retrieval, glucocorticoids partly interrupt the vicious cycle of retrieving, re-
experiencing and fear response, as well as re/consolidation of trauma/fear memory 
(Bentz et al., 2010; de Quervain et al., 2009a). 
Second, glucocorticoids might act beneficially by enhancing long-term consolidation 
of extinction processes. As a consequence of reduced re-experiencing symptoms 
and fear responses, a new corrective experience (extinction learning) can be stored 
in the extinction memory, which may be facilitated due to the consolidation 
enhancing effect of glucocorticoids (see Figure 4). 
 
Figure 4. Model of the role of cortisol in the modulation of trauma/fear memory. Cortisol might 
interrupt the vicious cycle of traumatic/fear memories (re-experiencing and conditioned fear 
responses) in two ways. On the one hand cortisol inhibits retrieval (1), fear responses (2) and 
re/consolidation (3) of trauma/fear memories (4) and on the other hand it facilitates the 
consolidation of extinction learning (5) and thereby enhances extinction memory (adapted from de 
Quervain et al., 2009) 
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First evidence for the beneficial effects of glucocorticoids comes from studies 
showing a prevention of PTSD by employing single high doses of glucocorticoids 
(i.e., hydrocortisone) to treat intensive care patients after physical trauma (e.g., 
after septic shock or cardiac surgery) (Schelling, 2002; Schelling et al., 2001; 
Schelling et al., 2004; Schelling et al., 1999). In line with these results, a study 
administering repeated low doses of hydrocortisone to physically traumatized 
patients showed a prevention of PTSD (Delahanty et al., 2013). However, these 
studies focused on the prevention of PTSD and administered cortisol while the 
traumatic experience was still fresh. Thus, these results cannot be applied to 
patients with a manifest PTSD. Furthermore, they did not directly investigate the 
effects of cortisol on retrieval processes such as intrusive memories. 
So far, there are two studies that have directly investigated the effect of cortisol on 
intrusive re-experiencing. In a pilot study (Aerni et al., 2004); three patients with 
chronic PTSD received a low dose of cortisol (10mg/d) over one month within an 
observation period of three months. Cortisol treatment reduced symptoms 
associated with traumatic memories (e.g., intrusion intensity in two patients, 
nightmare frequency in the third patient), but had no direct effect on self-rated 
intrusion frequency. However, in a Clinician-Administered PTSD Scale assessed after 
each month, re-experiencing symptoms showed cortisol-related improvements and 
in one patient also avoidance symptoms. Furthermore, there was evidence for 
cortisol effects that outlasted the treatment period, indicating that cortisol 
treatment might enhance consolidation of fear extinction processes. Ludäscher and 
colleagues (2015) aimed to replicate these findings in a larger sample of patients 
with chronic PTSD. In a double-blind, placebo-controlled, crossover design, 30 
female PTSD patients received daily over four weeks in a randomized order a 
placebo, 10mg and 30mg of hydrocortisone in order to compare the impact on 
intrusive re-experiencing. The first treatment group started with the administration 
of placebo during the first week, followed by 10mg hydrocortisone during the 
second week, the placebo the third week and finally, 30mg hydrocortisone during 
the fourth week. In the second treatment group, 30mg hydrocortisone was 
administered during the first week, placebo during the second week, 10mg 
hydrocortisone during the third week and placebo during the last week. In contrast 
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to the study of Aernie and colleagues (2004), they did not find any difference 
between the hydrocortisone therapies and placebo. There were no differences in 
the frequency or intensity of intrusive memories between the 10mg cortisol group, 
the 30mg cortisol group and the placebo group were found. Additionally, the overall 
symptomatology as well as the general psychopathology did not differ between the 
intervention groups. The generalizability of these results may be limited as the 
sample of Ludäscher and colleagues (2015) consisted only of chronically 
traumatized female patients with high comorbidity and different psychotropic 
medication. Thus, the findings regarding cortisol effects on intrusive memories are 
not consistent and emphasize the need for further research. 
Further support for the beneficial effects of glucocorticoids is provided by studies 
combining cortisol administration with exposure therapy. A study in PTSD patients 
showed that pairing cortisol and reactivation of a trauma memory, how it is 
normally done in exposure therapy, reduced the response to trauma reminders in 
PTSD patients (Surís, North, Adinoff, Powell, & Greene, 2010). Similarly, another 
study (Yehuda et al., 2014) demonstrated that veterans receiving cortisol (30mg) 
prior to the exposure sessions (ranging 3-10 in total) of a manualized PTSD therapy 
reported higher reduction in PTSD symptoms and had lower dropout rate than 
patients receiving placebo prior to therapy. It is important to note, that these 
beneficial results are not limited to patients with PTSD. A study examining the 
effects of cortisol in patients with phobic fears showed a reduction of fear 
symptoms in patients with spider phobia and social phobia (Soravia et al., 2006). A 
different study of Soravia and colleagues (2014) administered cortisol (20mg) prior 
to two sessions of in vivo exposure-based group therapy in spider phobia patients. 
They showed that cortisol treated patients have a greater reduction in fear of 
spiders as compared to placebo at the follow-up measurement one month after 
therapy, but not immediately after the treatment. Furthermore, the cortisol group 
reported less anxiety during the exposure to the spider at the follow-up compared 
to the placebo group. Additionally, in a placebo-controlled study individuals with 
acrophobia were given cortisol prior to exposure therapy, which produced 
facilitated extinction as measured 3-5 days or one month after the sessions (de 
Quervain et al., 2011). And lastly, studies obtaining endogenous elevated cortisol 
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concentrations due to the circadian rhythm of cortisol secretion with a peak in the 
morning, decreasing cortisol levels throughout the day and low levels in the evening 
and night, examined whether exposure is more effective in the morning than in the 
evening in patients with spider phobia (Lass-Hennemann & Michael, 2014) as well 
as in patients with panic disorder and agoraphobia (Meuret et al., 2015; Meuret et 
al., 2016). The results in all three studies revealed less fear in patients of the 
morning group compared to patients in the evening group, suggesting that early-
day extinction-based therapy yield better outcomes than latter-day sessions. 
So far, a conclusion as to whether the therapy enhancing effects of cortisol stem 
from strengthening the consolidation of extinction memory or from inhibiting 
effects on retrieval of trauma/fear memories or from a combination of both effects 
is not possible. In the above mentioned studies cortisol levels were elevated or 
cortisol was administered prior to exposure sessions leaving it an open question 
which cortisol mechanism is associated to the beneficial effects. Thus, further 
studies examining these different processes (inhibited fear retrieval and/or better 
consolidation of new no-fear memory acquired in exposure) of cortisol are needed. 
The suitable way to investigate these two proposed effects of cortisol in the context 
of PTSD is in well controlled experimental settings. Frequently used models for the 
pathogenesis of PTSD and its treatment are the trauma film paradigm and fear 
conditioning paradigms (described in more detail in chapter 4). To date, so fare no 
studies have employed the trauma film paradigm to investigate the influence of 
cortisol on PTSD symptoms. Considering conditioning paradigms, various animals 
studies have shown that GCs play an important role in successful fear extinction and 
extinction memory (Barrett & Gonzalez-Lima, 2004; Blundell, Blaiss, Lagace, Eisch, & 
Powell, 2011; Yang et al., 2006; Yang, Chao, Ro, Wo, & Lu, 2007). However, 
conditioning studies in humans specifically investigating the influence of GCs on 
only one of the proposed effects are scare. Nevertheless, there are some studies 
reporting cortisol effects on fear conditioning processes (Bentz et al., 2013; Drexler 
et al., 2017; Hamacher‐Dang, Merz, & Wolf, 2015; Meir Drexler et al., 2015; Merz, 
Hermann, Stark, & Wolf, 2013). For example, a study by Bentz and colleagues (2013) 
showed that elevated cortisol levels (by using the cold pressure test) prior to 
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extinction leads to reduced memory retrieval of conditioned fear in men. In 
contrast, another study administering cortisol after acquisition showed impaired 
extinction of previously conditioned fear in men (Merz et al., 2013). Providing a 
possible explanation for the contrasting results, a study examining context-
dependent stress effects reported that post-extinction stress leads to context-
dependent ROF (Hamacher‐Dang et al., 2015). In addition, there are studies 
providing evidence of cortisol effects on reconsolidation (Drexler & Wolf, 2017; 
Meir Drexler et al., 2015) and on extinction memory in a predictive learning task 
(Drexler et al., 2017). 
However, the results so far remain controversial and they are not conclusive with 
regard to which of the two proposed cortisol effects on memory functions is 
responsible for the results. None of the studies directly examined the effects of 
cortisol administration on long-term consolidation of extinction processes in a fear 
conditioning paradigm or on re-experiencing symptoms in a controlled 
experimental setting. Thus, experimental studies are needed to elucidate the 
underlying memory mechanisms. 
4. METHODOLOGICAL PARADIGMS USED IN THIS THESIS 
4.1 Trauma film paradigm 
As it is clearly unethical to intentionally expose participants to a real-life traumatic 
experience, researchers have designed different kinds of stressors that model 
important aspects of real-life trauma and can cause similar symptoms as well as 
memory phenomena without putting individuals’ mental health at any risk. One model 
is the trauma-film-paradigm. It is an established procedure in trauma research that 
offers an experimental opportunity to investigate pre-/peri- and posttraumatic 
mechanisms in the development of PTSD (for a review, see Holmes & Bourne, 
2008). Healthy participants are exposed to traumatic film clips including scenes with 
physical as well as with sexual violence. These scenes reliable induce unpleasant 
feelings such as fear, sadness or even disgust, physiological stress responses and 
intrusive memories (Lass-Hennemann, Peyk, Streb, Holz, & Michael, 2014; Nixon, 
Cain, Nehmy, & Seymour, 2009; Streb, Mecklinger, Anderson, Lass-Hennemann, & 
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Michael, 2016). However, it is expected that such reactions to these films are of a 
temporary nature. In previous studies using the trauma-film-paradigm in non-clinic 
populations, the participants reported on average 4.5 memories within 1 week 
(Holmes, Brewin, & Hennessy, 2004) or within 2 weeks (Brewin & Saunders, 2001) 
after presentation of the film, which can be regarded as an acceptable burden. In 
the first study of this doctoral thesis, we used a modified version of the paradigm. A 
neutral sound of a passing train, presented every minute for six seconds, was 
integrated throughout the film clip. This sound served as conditioned stimuli (CS) 
and allowed to assess the reaction to it in a different paradigm, i.e.., intrusion-
triggering-task (ITT). The ITT enabled to test whether cortisol would also inhibit 
intrusions induced in an experimental setting despite natural occurring intrusions 
and in addition if physiological reactivity to a trauma reminder is reduced due to 
cortisol administration. 
4.2. Fear conditioning with traumatic film clips 
As already mentioned above, fear conditioning constitutes a well-established 
experimental paradigm in PTSD research regarding its development and 
maintenance. It describes the process by which an originally neutral stimulus by 
pairing with an aversive stimulus (unconditioned stimulus; US) acquires negative 
qualities and becomes a conditioned stimulus (CS+) that finally elicits a conditioned 
fear response (CR) without being paired with the aversive stimulus anymore. For 
example concerning to the case report from the beginning for Joe the smell of 
diesel, an original neutral stimulus, become an aversive conditioned stimulus (CS+) 
after it was paired with his dying comrade and friend and only the smell of diesel 
immediately rekindled certain horrific memories and feelings (CR). 
However, previous conditioning studies have been low on external validity with 
regard to natural occurring traumatic situations and the process of fear acquisition 
in reality (Wegerer, Blechert, Kerschbaum, & Wilhelm, 2013). So far, unconditioned 
stimuli (US) usually include electrical stimulation and other types of aversive 
stimulation such as loud noises, air blast, aversive odours, or aversive images (Lissek 
et al., 2005; Sehlmeyer et al., 2009). Thus, those stimuli have little in common with 
naturally occurring aversive stimuli and situations during a traumatic experience 
(Wegerer et al., 2013). To have a higher comparability with real traumatic 
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experiences we chose several traumatic film clips based on the trauma-film-
paradigm as US. The aversive film clips containing traumatic content (e.g., physical 
violence, torture and/or sexual violence) were used to simulate the confrontation 
with anxiety-inducing content as naturally as possible, e.g., traumatic film clips 
served as US and were paired with neutral faces as CS. This allows an investigation 
of GCs effects in a more naturalistic fear conditioning paradigm. 
5. RESEARCH OBJECTIVES OF THIS THESIS 
Taken together, there are some promising findings of the beneficial effects of 
cortisol as a treatment enhancer for PTSD, but, however, the results regarding the 
influence on intrusive memories are not consistent and remain controversial. In 
addition, clinical studies combining elevated cortisol concentrations with exposure 
therapy and the few available experimental fear conditioning studies do not allow 
drawing conclusions about the underlying mechanism of the beneficial cortisol 
effects. Hence, the aim of this doctoral thesis was two-fold. 
In a first study, the retrieval impairing effect of GCs was investigated. It was tested if 
repeated cortisol administration inhibits experimentally induced intrusions and 
recognition memory within a trauma film paradigm. In a double-blind placebo-
controlled design, participants watched a traumatic film clip in which the sound of a 
train was embedded. This sound cue allowed an investigation of intrusions even in a 
controlled setting (e.g., intrusion-triggering-task), as stimuli that are present during 
a trauma might later function as trauma reminders. Over the following three days of 
trauma exposure participants received either cortisol or placebo twice a day and 
were asked to monitor their intrusive memories using an electronic diary. 
Furthermore, explicit memory was assessed with a recognition test, and all 
participants completed the intrusion-triggering-task on day four. Based on previous 
findings, participants in the cortisol group were expected to show fewer and less 
distressing intrusive memories during the three treatment days as well as in 
response to the intrusion-triggering-task than participants in the placebo group. 
Further, we expected the cortisol group to show lower performance in the 
recognition task compared to the placebo group. 
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The second study aimed to investigate the consolidation enhancing effects of GCs 
on extinction learning, an underlying memory process of exposure therapy for 
PTSD. In a randomized double-blind design, participants were exposed to a fear 
conditioning paradigm using traumatic film clips as the US. The experiment took 
place on three consecutive days, including fear acquisition on day one, extinction on 
day two and reinstatement and test of reinstatement on day three. Participants 
received either a dose of cortisol (30mg) or placebo immediately after extinction 
learning. Fear was assessed on a behavioural level (e.g., US-expectancy, valence 
ratings of the CSs), as well as on a physiological level (e.g., fear potentiated startle 
and skin conductance responses). Participants in the cortisol group were expected 
to show lower fear responses during reinstatement and test of reinstatement than 
participants in the placebo group. 
The following chapters (II and III) contain the manuscripts based on experiments 1 
and 2, in their original form apart from minor formatting changes. 
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II STUDY 1 
Repeated cortisol administration does not reduce intrusive 
memories – a double blind placebo controlled experimental 
study 
Co-Authors: Tanja Michael, Elena Holz, Johanna Lass-Hennemann 
1. ABSTRACT 
PTSD is a severe mental disorder, which may develop after exposure to traumatic 
events and is characterized by intrusive memories. Intrusions are sudden brief 
sensory memories of the traumatic event, that cause immense distress and 
impairment in every day functioning. Thus, the reduction of intrusive memories is 
one of the main aims of PTSD therapy. Recently, the glucocorticoid cortisol has been 
proposed as a pharmacological option to reduce intrusive memories, because 
cortisol is known to have memory retrieval inhibiting effects. However, the research 
on the effects of cortisol administration on intrusive memories is not conclusive. 
The aim of the present study was to examine if repeated cortisol administration 
inhibits intrusions and recognition memory in an experimental study using the 
trauma film paradigm. In a randomized double-blind placebo controlled design 
participants were exposed to a traumatic film (known to induce intrusions in 
healthy participants) and received either a low dose of cortisol (20mg) or placebo 
on the three days following "trauma exposure". Intrusive memories were assessed 
with an Electronic Diary and an Intrusion Triggering Task. Furthermore, we assessed 
explicit memory for the traumatic film clip with a recognition test. Contrary to our 
predictions, the cortisol group did not report fewer intrusions than the placebo 
group nor did it show diminished performance on the recognition test. Our results 
show that sole cortisol administration after a traumatic experience cannot reduce 
intrusive re-experiencing. 
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2. INTRODUCTION 
PTSD is a severe mental disorder that may develop after exposure to traumatic 
events, and is associated with long-term distress and severe impairment in 
everyday functioning (Norman et al., 2007). PTSD is frequently considered a 
disorder of memory: On the one hand, patients show an inability to recall important 
aspects of the trauma, and on the other hand, they suffer from distressing intrusive 
memories of the trauma. Intrusive memories are sudden brief, sensory memories 
(mostly visual); in which components of the traumatic event are re-experienced 
(Ehlers et al., 2004). They cause immense distress and are easily triggered by a wide 
range of internal and external stimuli. If untreated, these intrusions remain for a 
lifetime and contribute to the preservation of the disorder (Michael et al., 2005). 
Thus treatment guidelines for PTSD assign high priority to interventions targeting 
intrusions. Although exposure based psychotherapy, especially prolonged exposure 
and EMDR is effective (Cusack et al., 2016), a substantial number of patients still 
suffer from PTSD after treatment (Schottenbauer et al., 2008) and treatment is 
associated with relatively high dropout rates (Schnurr et al., 2007). Thus, there is a 
high need for optimizing PTSD treatment and much research has focused on new 
intervention strategies designed to inhibit intrusive memories. 
Recently, the glucocorticoid cortisol has been proposed as a pharmacological option 
to reduce intrusive memories (Bentz et al., 2010; de Quervain, 2007). Cortisol is a 
human stress hormone, which is released by the adrenal cortex in a circadian 
rhythm and as a response to stress, and has numerous effects on peripheral and 
central physiological processes. Importantly, cortisol has been shown to modulate 
memory processes (for a review, see de Quervain et al., 2009; Het et al., 2005). It is 
well-established that high cortisol levels facilitate memory consolidation (e.g., 
Kuhlmann et al., 2005; Wolf, 2008), but inhibit retrieval of previously learned 
material (e.g., de Quervain et al., 2003; de Quervain et al., 1998; de Quervain et al., 
2000; Roozendaal, 2003). Exogenous cortisol administration as well as the cortisol 
increase in response to stress (e.g., Kuhlmann et al., 2005) and high basal cortisol 
levels (e.g., Ackermann et al., 2013) lead to an impaired memory retrieval (but, see 
Kuhlmann & Wolf, 2006; Rimmele et al., 2010 for contrary findings). Therefore, 
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cortisol may serve as a pharmacological support for reducing intrusive memories in 
PTSD patients by inhibiting the excessive retrieval of traumatic memories (Bentz et 
al., 2010). 
Cortisol administration has been shown to reduce the enhanced perceptual priming 
effect for neutral stimuli that are associated with a traumatic context (Holz et al., 
2014), which has been established as one memory mechanism contributing to 
intrusive memories (Michael et al., 2005). Additional support for the cortisol 
hypothesis comes from studies employing single high doses of hydrocortisone to 
traumatized patients in order to prevent the development of PTSD: Administering 
hydrocortisone to intensive care patients (after a physical trauma, e.g., septic shock 
or cardiac surgery) leads to a decrease in the incidence of subsequent PTSD 
(Schelling et al., 2001; Schelling et al., 2004; Schelling et al., 1999). Another study 
from Delahanty and colleagues (2013) showed that repeated low dose cortisol 
administration (20mg over 10 days) prevents PTSD in traumatic injury patients. 
Further support for the cortisol hypothesis comes from a study combining cortisol 
administration with exposure therapy in PTSD patients. Yehuda and colleagues 
(2014) showed that veterans, who received cortisol (30mg) prior to the exposure 
sessions (3-10) of a manualized PTSD therapy, have a higher reduction in trauma 
symptoms and are less likely to drop out from therapy than patients who received 
placebo prior to therapy. 
However, these studies focused on the prevention of PTSD or on the combination of 
exposure therapy and cortisol and did not directly investigate the effects of sole 
cortisol administration on intrusive memories. There are only two studies that 
directly investigated the effects of repeated exogenous cortisol administration on 
intrusive re-experiencing. Aerni and colleagues (2004) conducted a pilot study in 
three PTSD patients, showing that the administration of a low dose of cortisol 
(10mg/d) over 1 month had a beneficial effect on re-experiencing symptoms: 
cortisol reduced intrusion intensity in two male patients, but had no effect on 
intrusion frequency, while it reduced nightmare frequency in the third (female) 
patient, but had no effect on intrusion intensity or frequency. Recently, Ludäscher 
and colleagues (2015) aimed to replicate these findings in a larger sample of PTSD 
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patients. They compared the impact of a 10mg and a 30mg dose of hydrocortisone 
on intrusive re-experiencing in 30 female patients with PTSD in a randomized, 
double-blind, placebo-controlled, crossover design. They did not find any 
differences in the frequency or in the intensity of intrusions between the 10mg 
cortisol group, the 30mg cortisol group and the placebo group. However, the 
sample of Ludäscher and colleagues (2015) consisted of chronically traumatized 
patients with high comorbidity and different psychotropic medication, which may 
limit the generalizability of these results. 
Thus, the results regarding the influence of cortisol administration on PTSD 
symptoms in general and on intrusive memories specifically are not consistent and 
remain controversial. Hence, the aim of the present study was to analyze the 
influence of a repeated cortisol administration on intrusive memories in a 
controlled experimental setting. The trauma film paradigm is a well validated 
experimental paradigm, in which healthy participants are confronted with very 
aversive film clips. It is known to induce analogue PTSD symptoms, especially 
intrusive memories in healthy participants and has been successfully used in 
numerous studies to investigate PTSD-like-symptoms in controlled experimental 
settings (e.g., Bourne et al., 2013; Chou et al., 2014a; Chou et al., 2014b; Clark et al., 
2014; Lass-Hennemann et al., 2014; Streb et al., 2016). In the present study, 65 
healthy female participants were exposed to a “traumatic” film clip (trauma film 
paradigm). In a double-blind design they were randomly assigned to receive either a 
low dose of hydrocortisone (20 mg) or placebo on the three days following “trauma 
exposure”. We assessed intrusive memories of the trauma film using electronic 
diaries. Furthermore, explicit memory was tested with a recognition task after 
cortisol treatment on day four. Finally, we assessed cortisol levels as well as the 
physiological parameters electrocardiogram (ECG) and electrodermal activity (EDA) 
prior, during and after the “traumatic” event. Based on previous findings we 
expected participants in the cortisol group to show fewer and less distressing 
intrusive memories as well as a lower performance for recognition memory than 
participants in the placebo group, due to the cortisol inhibition effect. A subsidiary 
aim of the study was to investigate whether cortisol would also inhibit the 
physiological reactivity to trauma reminders in an ITT. 
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3. EXPERIMENTAL PROCEDURES 
3.1 Participants 
71 healthy female students were recruited at Saarland University, Germany, and 
were compensated for their participation (80 Euro). Participation was restricted to 
healthy, non-smoking, women with a body mass index (BMI) of 19–25 kg/m2. 
Because gender is known to modulate cortisol effects on memory in general (for a 
review, see Sandi, 2013; Sauro et al., 2003) and on memory retrieval (Wolf et al., 
2001), we only included female participants in order to have a well-sized 
homogenous sample. To minimize the influence of menstrual cycle phase on 
hormonal status only women with a regular use of monophasic oral contraceptives 
were included in this study. Participants using contraceptives containing 
drospirenone (e.g., Yasmin, Yasminelle or Petibelle) were excluded because 
drospirenone is an antagonist of the MR, which may affect the stress reactivity of 
the body through a modified cortisol release (Genazzani et al., 2007). Exclusion 
criteria were history of systematic or oral cortisol therapy, any pharmacological 
treatment, any current axis I disorder or psychotherapeutic treatment, previous 
traumatic experiences, severe acute or chronic physical disease, pregnancy and 
lactation, and participation in a pharmacological study within the past 3 months. 
We assessed exclusion criteria with a standardized screening interview. Participants 
were required to refrain from physical exercise and alcohol during the experimental 
days as well as caffeinated beverages starting 3h prior to experimental sessions. The 
study was approved by the ethical committee of the medical association of Saarland 
(Germany). All participants gave their written informed consent and confirmed by 
signature that they had informed the experimenter of their medical condition. The 
study is registered with the German Clinical Trial Register (DRKS00010687). 
3.2 Experimental Design and Procedure 
Participation included three appointments at our laboratory: an initial screening 
session clarifying study eligibility and two experimental sessions. On the three days 
in between the two experimental sessions participants took two daily doses of 
cortisol or placebo at home (10mg at 12 p.m. and 10 mg at 4 p.m.). The dose of 
cortisol was chosen based on previous studies regarding cortisol effects on memory 
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retrieval (see Het et al., 2005) and on PTSD symptoms (Delahanty et al., 2013). 
Cortisol was administered twice a day in order to induce a constant heightened 
cortisol level throughout the day. Further participants collected saliva samples 
(cortisol awaking responses, prior to pill intake and one hour after pill intake) and 
filled in the electronic diary following written and previously explained instructions. 
Prior to the experimental sessions (see Figure 5), the following questionnaires were 
completed: Becks Depression Inventory (BDI) (Hautzinger et al., 1994), Rumination 
Scale (Treynor et al., 2003) and State and Trait Anxiety Inventory (STAI-T) (Laux et 
al., 1981). All experimental sessions took place between 2 p.m. and 6 p.m. to 
control for the diurnal cycle of cortisol. 
Experimental session 1: After arrival at the laboratory, participants indicated their 
current stress level and completed a state anxiety questionnaire (STAI-S) (pre film). 
Participants were then requested to put on headphones and a five minute resting 
phase started during which the physiological measures (ECG and EDA) were 
recorded (pre film resting phase). Subsequently the trauma film was presented and 
participants were instructed to follow the events on the screen without interruption 
or closing their eyes. Moreover, to enhance self-relevance, they were asked to 
imagine that they were eyewitnesses of the presented situations. Physiological 
measures were continuously recorded throughout the film (during film) and 
continued for five minutes after the film ended (post film resting phase). 
Participants were then asked to rate subjective unpleasantness and arousal 
symptoms using visual analogue scales (0-10). Furthermore they rated which of the 
three scenes of the film was most distressing for them. The classification name of 
the film scenes were presented on the screen and participants indicated the most 
distressing one by pressing different keys on the keyboard. Additionally, 
participants completed the STAI-S again (post film) and were asked to indicate 
whether (and how many) intrusions occurred in the post film resting phase and to 
rate the distress of the intrusions on a visual analogue scale (0-10). Afterwards, 
participants received the electronic diaries for the assessment of intrusions during 
the following days. They were then seated in a different room where they provided 
saliva samples to assess the cortisol response to the trauma film. Finally, 
participants received protocol sheets for the next three days and a tablet jar with 6 
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pills of either cortisol or placebo. The electronic diaries were programmed to 
remind participants to take the cortisol/placebo pills at 12 p.m. and 4 p.m. on the 
following three days (see Figure 5). 
Experimental session 2: Experimental session 2 took place three days after 
experimental session 1. The session started with the last pill intake in our laboratory 
at 4 p.m. followed by a standardized waiting time, during which the participants 
watched a non-arousing film (35 min, “Relaxing: The most beautiful landscapes on 
earth”). The waiting time was integrated to allow cortisol concentrations to 
increase. Participants were asked to indicate their current stress level and to 
complete the STAI-S (pre ITT). They were then instructed to put on headphones and 
a three minute resting phase started during which the physiological measures (ECG 
and EDA) were recorded (pre ITT resting phase). Subsequently, the ITT was 
performed. The physiological recording continued throughout the ITT (during ITT) 
and for 3 more minutes after the task ended (post ITT resting phase). Participants 
completed the STAI-S again (post ITT) and a paper-pencil questionnaire, which 
queried the spontaneous occurrence of intrusions and their distress during the last 
post ITT resting phase. Finally, participants were led to another room, where they 
performed the recognition task and provided one more saliva sample (for an 
overview of the experimental procedure, see Figure 5). 
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Figure 5. Study design. The experiment included three appointments: pre-screening one week prior 
to the experiment (including a screening interview, two basal cortisol awakening responses (CAR), 
State-Trait-Anxiety-Inventory (STAI-T), Becks-Depression-Inventory (BDI) and rumination scale); and 
two experimental sessions (Day 1 and Day 4). On the first experimental session (Day 1) the trauma 
film was presented and on the second experimental session (Day 4) the Intrusion Triggering Task 
(ITT) and recognition task were performed. During both experimental sessions saliva samples were 
collected and physiological parameters (ECG and EDA) were assessed. In the days between the two 
experimental sessions (Day 2/3/4) participants took either cortisol (10mg twice a day) or placebo, 
provided saliva samples and recorded their intrusive memories via E-Dairy. 
3.3. Materials and Measures  
3.3.1 Trauma film 
The 11-minute trauma film consisted of three extremely aversive scenes (sexual 
violence towards a woman, physical violence against the same women, and physical 
violence among men) of the film “Irreversible” by Gaspar Noé (2002). These scenes 
have been used in previous studies and have been shown to reliably induce 
intrusive memories (Nixon et al., 2009; Streb et al., 2016) and physiological as well 
as subjective stress responses in healthy participants (Lass-Hennemann et al., 2014). 
In our study we used a modified version of the paradigm. We integrated a neutral 
sound of a passing train into the trauma film. It was presented every minute for six 
seconds throughout the film clip. This sound served as conditioned stimuli (CS) and 
the reaction to it was assessed on the second experimental session with the ITT. 
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3.3.2 Intrusion Triggering Task  
This task is based on the memory triggering task by Wegerer et al. (2013), which 
was designed to model daily life situations in which trauma survivors might 
experience intrusions and the potential of CS sound cues to trigger intrusive 
memories. During the ITT, participants were instructed that they should look at the 
black screen and let their mind wander, while they would hear a background 
soundscape via headphones. The ITT consisted of 3 almost identical soundscapes, 
which was a bubble of voices with neither content nor language identifiable and 
lasted for three minutes. Only in the second soundscape the passing train sound 
from the trauma film was presented. The sound was embedded in the soundscape 
and occurred every 30 seconds for a duration of six seconds. The presentation of 
the previous conditioned stimulus (passing train sound) should lead to renewed 
episodes of intrusions and these were assessed in the resting phase after the ITT. 
3.3.3 Recognition Task  
30 statements about the content of the trauma film (e.g., the female victim was 
wearing a red dress) were presented on a computer screen and participants had to 
indicate whether these statements were true or false by pressing different keys. 
The statements were presented for 10 seconds and the inter-stimulus interval was 
set to 5 seconds. Participants were instructed to respond as accurately and rapidly 
as possible. To insure applicability of the statements we conducted a pilot study 
with 10 participants, in which participants were asked to classify 60 statements 
about the trauma film as true or false. Statement quality was based on the quantity 
of correctly identified true and false items. For the final recognition task we only 
selected statements which were on average correctly detected from 6-8 out of 10 
participants. This reflects a moderate statement complexity.  
3.3.4 Ambulatory assessment of intrusive memories 
To assess intrusive memories we used an iPod Touch (4th gen., Apple Inc., 
Cupertino, USA) with the software Forms VI (Pendragon Software Corporation, 
Chicago, USA). Participants were asked to carry the iPod with them all times during 
their daily routine for the following three days after film presentation. They were 
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instructed to report every intrusive memory immediately after it occurred. 
Intrusions were defined as spontaneous involuntary memories which could include 
images, noises, emotions and thoughts. Participants were asked to only report 
intrusions that were related to the trauma film and/or to the experiment in general. 
Additionally, participants rated the distress caused by each intrusion on a 10 point 
rating scale (0-10) ranging from “not at all” to “extremely”.  
3.3.5 Subjective stress ratings, anxiety and physiological measurements 
Subjective stress ratings. At the beginning of every experimental session, we 
assessed if participants experienced a stressful event in the last 24 hours (current 
stress, e.g., conflict with someone or an exam). Furthermore, we assessed 
subjective arousal and unpleasantness on day one (post film), which were rated on 
two visual analogue scales from 0 to 10 (no physical reactions to very strong 
physical reactions; very pleasant to very unpleasant) on the computer screen.  
STAI. We used the German version of the trait scale of the State-Trait-Anxiety-
Inventory (STAI-T) as a baseline anxiety trait measurement and the German version 
of the state scale of the State-Trait-Anxiety-Inventory (STAI-S) (Laux et al., 1981) to 
measure participants’ change in level of anxiety as a response to the “traumatic” 
film and to the ITT. The STAI can reach scores from 20 to 80 with lower scores 
indicating lower anxiety levels and higher scores indicating higher anxiety levels.   
BDI. To measure depression symptoms for the previous week we used the German 
version of the Beck Depression Inventory (BDI) (Hautzinger et al., 1994). This 
questionnaire can reach scores from 0 to 63 with higher scores indicating more 
depressive symptoms. A score above 17 is considered to be clinically relevant. 
Rumination Scale. We used the German translation of the Ruminative Responses 
Scale (RRS) (Treynor et al., 2003) to assess trait rumination. The scores of this 
questionnaire can reach from 22 to 88, with higher scores indicating more trait 
rumination. 
3.3.6 Physiological measurements 
Physiological data were recorded by ActiveTwo Software (BioSemi, Amsterdam, 
Netherlands) and were continuously digitized with a sample frequency of 512 Hz 
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per channel using a 24-bit A/D converter. Further analyses were conducted using 
the software Autonomic Nervous System Laboratory (ANSLAB) version 2.6 (Blechert 
et al., 2016). 
ECG. A standard Lead-II ECG with two standard Ag/AgCl electrodes filled with 
isotonic electrode gel was used for ECG measurements. R-waves were identified 
automatically by ANSLAB 2.6 and edited manually for artefacts, false positives or 
non-recognized R-waves and transformed into instantaneous inter-beat-intervals 
(IBI) and instantaneous heart rate (HR). IBI as well as HR were calculated for the 
time phases of interest [first experimental day: pre film resting phase (5min), during 
film (11min) and post film resting phase (5min); second experimental day: pre ITT 
resting phase (3min), during ITT (9min) and post ITT resting phase (3min)]. 
EDA. Two Ag/AgCl electrodes filled with isotonic electrode gel were attached to the 
proximal part of the palm of the participants´ non-dominant hand (with an 
alternating current of 1mA synchronized with the sampling frequency passed 
between the electrodes). The raw signal was decimated to 25 Hz and then manually 
edited for artefacts and smoothed using a 1 Hz low-pass filter. Skin conductance 
level (SCL) was calculated as the average of all sampling points across the relevant 
time phases. Further the signal was scanned for significant rises greater than 0.02 
micro Siemens, to quantify the number of non-specific skin conductance 
fluctuations (nsF) for the same time phases. 
Cortisol. Saliva samples were collected using Salivette tubes (Saarstedt). To assess 
the basal cortisol reaction (i.e., CAR), participants provided four saliva samples 
(awake, +30, +45, +60 min) on two consecutive mornings prior to the experimental 
sessions. The cortisol response to the trauma film clip was assessed with seven 
saliva samples: one sample immediately upon arrival of the participants at the 
laboratory (arrival), one sample prior to the film presentation (pre-film), one sample 
directly after film presentation (post-film, +0min), four samples at intervals of 15 
minutes after film presentation (+15min, +30min, +45min and +60min) and one 
more at 10 p.m.. As a manipulation check and to validate the success of the 
pharmacological intervention during the three treatment days, participants 
collected saliva samples four times per day: immediately before (12 p.m., 4 p.m.) 
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and one hour after (1 p.m., 5 p.m.) pill intake. Participants also collected saliva 
samples for the CAR (as described above) and at 10p.m. during the treatment days. 
The cortisol response to the ITT was measured with one sample 15 minutes after 
the task. The samples were kept at -20°C until analysis. Saliva cortisol was analyzed 
at the cortisol laboratory of the University of Trier, Germany. After thawing the 
saliva samples for biochemical analysis, the fraction of free cortisol was determined 
using a time-resolved immunoassay with fluorometric detection, as described in 
detail elsewhere (Dressendörfer, Kirschbaum, Rohde, Stahl & Strasburger, 1992). 
For the CAR we calculated the area under the curve with respect to ground (AUCg) 
(Pruessner, Kirschbaum, Meinlschmid & Hellhammer, 2003). The AUCg calculates 
the total area under the curve of all measurements as the area of interest and 
described by Pruessner and colleagues (2003) this takes the difference between the 
single measurements from each other and the distance of these measures from the 
ground or zero in account. 
3.4 Statistical analysis  
All data analyses were performed using SPSS (IBM SPSS Statistics 21). The alpha 
level was set at p< 0.05 and Greenhouse–Geisser corrected p-values are reported if 
assumptions of sphericity were violated. Effect sizes are reported as partial η2. 
4. RESULTS 
4.1 Participants characteristics 
A total of 9 participants were excluded from analysis; 6 participants discontinued 
the study and 3 further participants had to be excluded due to technical problems 
during data collection. The final sample consisted of 32 participants in the cortisol 
group (Mage=21.47 years, SD=2.78, MBMI=21.47, SD=2.1) and 33 participants in the 
placebo group (Mage=22.42 years, SD=2.32, MBMI=21.59, SD=2.11). Groups did not 
differ in age (F1,60=1.865, p=.177), BMI (F1,60=.018, p=.894), basal cortisol 
concentrations (F1,60=1.988, p=.164), Depression (BDI)  (F1,60=1.896, p=.174), Trait 
Anxiety (STAI-T) (F1,60=.631, p=.430) or Rumination (Rumination Scale) (F1,60=1.371, 
p=.246) prior to testing. Data are presented in Table1. 
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Table 1. Participants characteristics in the cortisol and the placebo group 
 Cortisol Group (N = 32) 
M (SD) 
Placebo Group (N = 33) 
M (SD)  
Age 21,47 (2,78) 22,42 (2,33) 
BMI 21,47 (2,09) 21,59 (2,11) 
CAR (AUCG) 696,09 (271,91) 627,47 (190,2) 
BDI 6,97 (6,05) 4,73 (5,11) 
STAI-T 37,06 (6,37) 35,42 (7,47) 
Rumination Scale 41,63 (11,02) 38,7 (8,81) 
BMI: Body Mass Index, CAR: cortisol awakening response, BDI: Becks Depression Inventory, STAI-T: 
State-Trait-Anxiety-Inventory-Trait 
4.2 Manipulation check 
4.2.1 Day 1: Trauma film 
Subjective stress ratings. None of the participants reported a relevant stressful 
event in the 24 hours prior to the experimental session. Participants´ subjective 
stress ratings immediately after the film indicated high subjective unpleasantness 
(M=8.09, SD=1.84) and arousal (M=6.02, SD=2.5) as reactions to the trauma film. To 
analyze differences in subjective stress ratings between the two groups we 
conducted a MANOVA with the between-subject factor Group (cortisol, placebo) 
and the dependent variables unpleasantness and arousal. The two groups did not 
differ in their subjective stress ratings (no main effect of Group on unpleasantness, 
p=.318 or on arousal, p=.789). 
State anxiety. To analyze the influence of the “traumatic” event on state anxiety, 
we conducted a one way ANOVA with Time (pre-film, post-film) as the independent 
variable and STAI-S as the dependent variable. State anxiety increased from pre-to 
post-film assessment (main effect of Time for state anxiety (STAI-S), F1,63=99.797, 
p<.001, η2=.613). As expected, there was no significant Time x Group interaction 
(p=.953) showing that both groups experienced a comparable increase in state 
anxiety after the trauma film. 
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Figure 6. Salivary cortisol in nanomole per litre as a response to the “traumatic” event. Black line 
represents the cortisol group, the grey line represents the placebo group. 
Physiological measures. We conducted a MANOVA with Time (pre-film, during film, 
post-film) as the within-subject factor and with Group (cortisol, placebo) as the 
between-subject factor to analyze the effects of the “traumatic” event on 
physiological measurements (HR, IBI, SCL, nsF). We found significant main effects 
for HR, IBI and spontaneous fluctuations of EDA (all ps<.000). Planned comparisons 
revealed that participants showed an increase in heart rate and in spontanous 
fluctuations of EDA along with a decrease in inter-beat-interval during the film as 
compared to the pre- and post-film physiological measurement (all ps<.02). 
However, the main effect of Time was not significant for SCL (p=.810). There was 
also no significant interaction between Time and Group for any of the dependent 
variables (all ps >.116), confirming no differences between the two groups in their 
physiological reaction to the “traumatic” event (see Table 2). 
Cortisol level. To analyze participants´ cortisol response to the “traumatic” event 
we conducted a mixed design ANOVA with the within-subject factor Time (pre1, 
pre2, +0min, +15min, +30min, +45min and +60min post trauma film) and the 
between-subject factor Group (cortisol, placebo). Significant results were followed 
by planned comparisons via t-test. There was a significant main effect of Time 
(F6,366=6.378, p<.002, η2=.095), indicating that cortisol levels increase in response to 
the film and then return to baseline (see Figure 6). The interaction Time x Group 
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was not significant, showing that the increase in cortisol as a reaction to the 
“traumatic” event did not differ between the two groups (F6,366=1.27, p=.286). 
4.2.2 Cortisol administration 
Manipulation check of cortisol intake during the three treatment days. To confirm 
a rise in salivary cortisol concentrations after cortisol administration over the three 
treatment days, we averaged the pre and post cortisol-values over the three days 
and conducted a mixed design ANOVA with the within-subjects factors Time (noon, 
afternoon) and Pre- /Post-values (pre and 60 min after pill administration) and the 
between-subjects factor Group (cortisol, placebo). The analysis revealed that the 
cortisol concentration differed from noon to afternoon (significant main effect of 
Time, F1,62=8.458, p=.005, η
2=.120) and from pre to post pill administration 
(significant main effect of Pre-/Post-values, F1,62=47.879, p<.001, η
2=.436). Both 
measures interacted with the Group factor (significant Time x Group interaction, 
F1,62=12.447, p=.001, η
2=.167; significant Pre-/Post-value x Group interaction, 
F1,62=50.453, p<.001, η
2=.449). Pairwise comparisons showed significant differences 
from the pre- to post-time point for both groups (p<.05), indicating a clear rise in 
cortisol concentrations upon hydrocortisone intake in the cortisol group, and a 
natural circadian decrease in cortisol concentration in the placebo group. To 
provide further information on how the cortisol/placebo manipulation changes the 
diurnal cortisol profile, we conducted a mixed design ANOVA for the diurnal cortisol 
profile (AUCg) with the between subject factors Day (day1, day2, day3, day4) and 
Group (cortisol, placebo). The analysis revealed a main effect of Day (F3,186=11.399, 
p=.000, η2=.155) and a significant Day x Group interaction (F3,186=9.308, p=.000, 
η2=.131), indicating an increased diurnal cortisol profile in the cortisol group as 
compared to the placebo group. Planned comparison showed that the two groups 
did not differ on the first experimental day (day of trauma-film-presentation), but 
that they significantly differed from each other with the beginning of the 
cortisol/placebo treatment (see Figure7B). For the raw data please see 
supplementary material. 
Cortisol awakening response during the three treatment days. Further, we 
compared the CAR over the three treatment days by conducting a mixed design 
ANOVA with Day (day2, day3, day4) as within-subject factor and Group (cortisol, 
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placebo) as between-subjects factor. The analysis yielded a significant main effect 
of Day (AUCg: F2,124=10.545, p<.001, η
2=.054), and a significant Day x Group 
interaction (AUCg: F2,124=12.642, p<.001, η
2=.169). Figure 7A shows that the CAR 
decreased significantly over the three treatment days in the cortisol group, but not 
in the placebo group. This is an indication for a well-functioning negative feedback-
loop of cortisol distribution and also indicates that the cortisol manipulation was 
successful. 
 
Figure 7. (A) Cortisol awakening response (CAR) during the three treatment days. Black lines 
represent the cortisol group; grey lines represent the placebo group. AUCg=Area under the curve 
with respect to the ground. Significant difference between the cortisol and placebo group (t-tests) 
are indicated with **=p<.01, *=p<.05 (B) Cortisol diurnal profiles assessed with the area under the 
curve with respect to the ground (AUCg) compared over the four experimental days. Black lines 
represent the cortisol group; grey lines represent the placebo group. **=p<.01, significance 
difference between cortisol and placebo group (t-tests). Please note that on day 4 the 10p.m. sample 
is not included in the analysis, because the experiment ended at 5.30p.m., which limits the 
comparability of the AUCg on day 4 as compared to the other treatment days. 
4.2.3 Day 4: ITT 
State anxiety. To analyze participants´state anxiety in response to the ITT, we 
conducted a mixed design ANOVA with Group (cortisol, placebo) as the between-
subject factor, Time (pre- and post-ITT) as the within-subject factor and state 
anxiety (STAI-S) as dependent variable. There was a main effect of Time 
(F1,63=25.48, p<.001, η2=.288), showing that there was a significant increase in 
anxiety from pre to post ITT. However, there was neither a significant main effect of 
Group nor a Time x Group interaction (all ps>.194). Both groups experienced a 
comparable increase in anxiety in response to the ITT. 
Physiological measurements. To examine participants´ physiological reaction to the 
ITT, we conducted a mixed design MANOVA with Group (cortisol, placebo) as the 
between-subject factor and Time (pre- and post-ITT) as within-subject factor. HR, 
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IBI, SCL and nsF were dependent variables. Participants showed an increase in nsF 
(F2,120=8.326, p<.001, η2=.122) and in SCL (F2,120=14.111, p<.001, η2=.190) during the 
ITT as compared to the pre- and the posttest measurement (see Table2). However, 
there was no significant effect for HR (F2,120=1.146, p=.290) and for IBI (F2,120=2.299, 
p=.134). Again, there was no significant main or interaction effect for Group, 
indicating that the cortisol and the placebo group showed a comparable 
physiological reaction to the ITT (all ps>.339). 
Table 2. Physiological responses as a reaction to the trauma film and the ITT 
  Trauma Film ITT 
  Cortisol(N=29) 
M (SD) 
Placebo (N=31) 
M (SD) 
Group 
comparison 
Cortisol(N=31) 
M (SD) 
Placebo (N=31) 
M (SD) 
Group 
comparison 
 
HR 
pre 76,48(12,84) 81,00 (14,69) F2,116= 
1.124 
p=.31 
99,41(158,00) 76,47(10,03) F2,120= 
0.932 
p=.34 
during 80,48 (14,08) 87,00 (14,08) 71,53 (11,39) 76,52 (11,32) 
post 75,10 (12,39) 78,55 (14,65) 71,09 (10,59) 73,58 (16,22) 
 
IBI 
pre 812,97(140,06) 769,65(138,68) F2,116= 
.760 
p=.457 
862,55 (151,69) 809,10(116,80) F2,120= 
0.074 
p=.80 
during 778,14 (152,89) 723,68(141,43) 868,70 (154,69) 806,30 (126,01) 
post 827,79 (144,15) 793,69 (149,14) 831,99 (177,96) 762,16 (216,82) 
 
nsF 
pre 5,06 (3,93) 4,41 (3,78) F2,116= 
2.233 
p=.116 
11,55 (11,47) 12,13 (10,90) F2,120= 
0.052 
p=.94 
during 8,1377 (5,07) 9,36 (4,01) 15,65 (12,43) 15,55 (11,43) 
post 5,56 (3,58) 5,78 (3,26) 11,71 (11,90) 11,84 (8,71) 
 
SCL 
pre 12,66 (29,84) 7,97  (4,51) F2,116= 
1.241 
p=.270 
6,60 (5,51) 7,06 (4,48) F2,120= 
0.525 
p=.53 
during 9,31 (5,83) 11,18 (6,09) 8,17 (5,22) 8,85 (5,49) 
post 10,56 (6,02) 11,33 (6,43) 7,13 (5,07) 8,23 (5,81) 
HR: heart rate; IBI: inter-beat-interval; nsf: non-specific fluctuations; SCL: skin conductance level. 
4.3 Test of assumptions 
4.3.1. Intrusions as a reaction to the trauma film 
Intrusion frequency and distress were averaged for each participant for the first day 
(immediately after trauma induction) as a baseline intrusion measurement (before 
cortisol/placebo treatment) and over the three treatment days. To analyze the 
influence of cortisol administration on intrusions we conducted two mixed design 
ANOVAs with the factors Group (cortisol, placebo) and Time (day 1, treatment days) 
with the dependent variable frequency und disstress. The cortisol and placebo 
group did not differ regarding intrusion frequency (no main effect of Time: F1,59=.09, 
p=.765; no interaction effect: F1,59=.047. p=.829) or intrusion disstress (no main 
effect of Time: F1,42=3.413, p=.072; no interaction effect: F1,42=.828, p=.368). 
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Examining intrusion frequency seperatly for each day we found a main effect of 
Time (F3,180=21.765, p<.001, η2=.266), showing the previously described effect that 
intrusion frequency to an analogue trauma decreases in course of time (see Figure 
8). However, in contrast to our expectations there was no significant interaction 
between Time and Group (F3,180=0.627, p=.497). Participants in the cortisol group 
did not report fewer and less distressing intrusions than participants in the placebo 
group. 
 
Figure 8. Baseline intrusion measurement (day 1 = day of trauma film presentation) compared to 
intrusion measurement during the three treatment days (day2/3/4= cortisol/ placebo 
administration) for mean intrusion frequency (A) and intrusion distress (C). (B) Intrusion frequency 
separately for each day, the cortisol/placebo administration was on day2, 3 and 4. 
4.3.2 Intrusions as a reaction to the ITT 
For the effects of the ITT we calculated the mean intrusion frequency and distress 
for the resting phase after the ITT and conducted a one way MANOVA with Group 
(cortisol vs. placebo) as independent variable. We were able to demonstrate that 
the ITT provoked intrusions in both groups (cortisol group: M=2.47, SD=1.95; 
placebo group: M=2.22, SD=2.39) with a moderate distress (cortisol group: M=3.44, 
SD=2.75; placebo group: M=2.77, SD=2.79). However, there was no significant 
interaction between the two groups, again showing no influence of our cortisol 
manipulation on intrusion measures (frequency: F1,57=.190, p=.664; disstress: 
F1,59=.867, p=.356). 
4.3.3 Recognition task 
Memory performance was based on statements correctly identified as true or false 
by computing the sensitivity score (d’= standardized hits – standardized false 
alarms). Effects of cortisol administration on recognition performance were 
analyzed with a one way between-subject ANOVA with Group (cortisol vs. placebo) 
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as independent variable. Both groups showed a comparable memory performance 
with respect to the content of the trauma film (no significant main effect, 
F1,60=1,167, p=.285). 
5. DISCUSSION 
The aim of the present study was to investigate the influence of repeated cortisol 
administration on experimentally induced intrusive re-experiencing in healthy 
women. Participants showed an increase in physiological arousal as well as 
subjectively experienced distress after the “traumatic” film clip and both groups 
differed in their cortisol level after cortisol/placebo intake, indicating a successful 
experimental “trauma induction” and cortisol manipulation. However, in contrast to 
our expectations, there was no significant difference in intrusion frequency or 
intrusion distress between the cortisol and the placebo group, showing that 
repeated cortisol administration after an experimentally induced trauma does not 
reduce intrusive memories. Thus, our results are not in line with the assumption 
that the inhibiting effect of cortisol on memory retrieval also leads to a reduction in 
trauma memory retrieval (de Quervain, 2006). The previous research regarding this 
question has been controversial. Aerni and colleagues (2004) found a beneficial 
effect of a low dose of cortisol on the daily rated symptoms of traumatic memories 
in three PTSD patients. However, the study of Aerni and colleagues (2004) only 
included three patients and the results were not conclusive. Cortisol reduced 
intrusion intensity in two male patients, but had no effect on intrusion frequency, 
while it reduced nightmare frequency in the third (female) patient, but had no 
effect on intrusion intensity or frequency. Ludäscher and colleagues (2015) tried to 
replicate the findings of Aerni and colleagues (2004) in a bigger sample and did not 
find an inhibiting effect of cortisol administration on intrusive memories in their 
sample of 30 chronically traumatized female PTSD patients. One of the main 
limitations of the study by Ludäscher and colleagues (20015) is that their sample 
consisted of chronically traumatized patients with high comorbidity rates and 
different psychotropic medications, which limits the generalizability of their results. 
Our study consisted of a healthy sample in a very controlled experimental setting, 
and we also did not find an influence of repeated cortisol administration on 
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intrusive memories. However, our study as well as the study of Ludäscher and 
colleagues (2015) investigated female participants/patients only. There is 
accumulating evidence showing that the effects of cortisol on memory processes in 
general (for a review, see Sandi, 2013; Sauro et al., 2003) and on memory retrieval 
differ between men and women (Wolf et al., 2001). Furthermore, it has been shown 
that sex hormones have an impact on the formation of intrusive memories, e.g., 
salivary estrogen in women is associated with increased intrusions (Ferree et al., 
2011). Therefore, the results of a female sample taking oral contraceptives might 
not easily be generalized to free-cycling women and to men. However, the majority 
of PTSD patients are women and even though the use of contraceptives is declining, 
it is still one of the most frequently used contraceptive methods. Thus, we can 
assume that a substantial proportion of female PTSD patients are taking oral 
contraceptives and our results are highly relevant for these patients. Nevertheless, 
future experimental studies as well as clinical studies in PTSD patients should 
compare the effects of cortisol administration between males and between free-
cycling female participants and those who use oral contraceptives. 
In seeming contrast to our findings some studies have reported positive effects of 
cortisol administration on the development of PTSD and PTSD symptoms. However, 
these studies either focused on the prevention of PTSD by applying high doses 
(Schelling, 2002; Schelling et al., 2001; Schelling et al., 2004; Schelling et al., 1999) 
or repeated low doses (Delahanty et al., 2013) of cortisol to physically traumatized 
patients  or on the combination of cortisol and exposure (therapy) (Surís et al., 
2010; Yehuda et al., 2015). The study series by Schelling and colleagues consistently 
found lower PTSD rates in intensive care unit patients after a single high dose of 
hydrocortisone. However, Schelling´s samples consisted of a very specific group of 
physically traumatized patients, in which cortisol may have directly impacted on the 
disease and therefore on the stressfulness of the ongoing traumatic event. On that 
account, the data of these studies are not comparable to our study design. More 
similar to our design is the study by Delahanty and colleagues (2013) that 
investigated a sample of traumatic injury patients who received low doses of 
cortisol (20 mg) within 12 hours of hospital admission over 10 days. They found a 
reduced PTSD rate after one and after three months. Furthermore, all these studies 
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assessed PTSD symptoms in general, but none directly investigated the impact of 
cortisol on intrusive re-experiencing symptoms. In sum, these studies suggest a 
beneficial effect of cortisol administration on the prevention of PTSD in traumatic 
injury patients. But whether this effect is mediated by an inhibiting effect of cortisol 
on re-experiencing symptoms or other mechanisms has not yet been explored. 
Studies on the combination of high cortisol and exposure (therapy) in PTSD (Surís et 
al., 2010; Yehuda et al., 2015) and other anxiety disorders (Bentz et al., 2013; Lass-
Hennemann and Michael, 2014; Soravia et al., 2006) also yielded positive results. 
However, these studies may have targeted different memory processes than our 
study. While our study clearly focused on the retrieval inhibiting effect, that is the 
intrusion reducing effect, of cortisol, cortisol administration in Yehudas (2015) and 
Surís (2010) study was prior to an exposure to traumatic material and thus should 
have targeted cortisol effects on memory retrieval and memory consolidation. 
Additionally, Surís and colleagues (2010) found an influence of cortisol 
administration on the IES-R in general, but not on the intrusion subscale of the IES-
R, which is in line with our null-findings regarding the effects of cortisol 
administration on intrusive re-experiencing. 
We also did not find an effect of cortisol administration on the recognition memory 
for the “traumatic” event assessed with a true/false recognition memory task three 
days after the trauma film. Thus, cortisol administration also did not influence 
declarative memory performance in our study. 
Some limitations of our study have to be taken into account. Even though cortisol 
administration led to a significantly increased diurnal cortisol profile, we found a 
reduced CAR on the second and third treatment day in the cortisol group as 
compared to the placebo group. This decline in morning cortisol is probably due to 
the negative feedback function of cortisol in healthy individuals, which regulates 
cortisol synthesis to protect the body from persistent elevated cortisol levels. Thus, 
cortisol levels in the cortisol group were lower in the morning and mainly increased 
in the afternoon and evening. One may argue that the lack of an effect of cortisol 
administration on intrusive re-experiencing symptoms is due to the lower morning 
cortisol levels in the cortisol group. However, there are at least two strong 
arguments against this point. First, we find the same null effect for cortisol 
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administration on intrusive memories for treatment day 1 on which groups did not 
differ in their morning cortisol levels. Second, in our sample intrusions mainly 
occurred in the afternoon and the evening2  when cortisol levels where higher in the 
cortisol group. Furthermore, it is important to note that previous studies that 
repeatedly administered cortisol in order to reduce intrusive re-experiencing 
symptoms, administered cortisol once a day. We administered cortisol twice a day 
to ensure a constant elevated cortisol level throughout the day. However, our data 
showed that even a dose of 20mg of cortisol administered twice a day did not lead 
to “constantly” increased cortisol levels in healthy participants. This has to be taken 
into account when trying to heighten cortisol levels by cortisol administration. In 
addition, the question arises how the CAR in PTSD patients might be influenced by 
repeated cortisol administration as PTSD patients often show a dysfunctional 
cortisol synthesis. Thus, one could assume that the negative feedback function is 
not as reactive in PTSD patients as in healthy controls. Additionally, with our 
experimental design, it was not possible to align the time points of cortisol/placebo 
administration with the timing of intrusions. Thus, we cannot rule out that 
intrusions occurred shortly before cortisol or placebo administration and in these 
cases cortisol administration might have enhanced the consolidation of intrusive 
memories. 
Further limitations concern the use of an analogue paradigm in healthy participants 
instead of investigating the influence of cortisol administration on intrusive re-
experiencing in PTSD patients. It must be emphasized that watching a “traumatic” 
film is not comparable to experiencing an actual traumatic event. However, real life 
assessments in patients create various challenges and problems that can be 
circumvented by analogue designs. The trauma film paradigm represents the gold 
standard in examining key processes and factors in PTSD (Holmes and Bourne, 
2008), such as intrusions. As in many previous trials, our participants exhibited 
intrusions accompanied by moderate distress in the days following exposure to the 
                                                     
2
 In our study about 81% of the captured intrusions occurred in the afternoon and evening. This is 
probably due to the fact that rumination triggers intrusion (Holz et al., 2017) and clinical 
observations indicate that rumination mainly occurs in the afternoon/ evening. To check if there is a 
difference between the cortisol and placebo group if we only consider intrusions in the afternoon 
after cortisol/placebo manipulation we conducted a two sample t-Test. We did not find a group 
differences regarding mean intrusion frequency between the two groups (t(57)=1.492, p=.141). Note 
that due to technical problems the time points of intrusions of eight participants are missing. 
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“traumatic” event, which was experienced as very unpleasant and arousing. 
Moreover, the film clip induced both high psychological stress and physiological 
arousal. Thus, our paradigm led to the expected analogue symptoms. Nonetheless, 
generalizability may be restricted since for ethical reasons only healthy participants 
without any psychopathology and without prior traumatic experiences were 
included. 
Another limitation is related to the sensitivity of the task: Even though the 
measurement of intrusions with electronic diaries is a very good method to assess 
intrusive memories (Pfaltz et al., 2013), it relies on self-report, and recent research 
has shown that participants do not always recognize their intrusions and do 
sometimes not report those (Takarangi et al., 2014). Also, a floor effect due to the 
overall small number of intrusive memories cannot be ruled out. However, we did 
not only access intrusions with an electronic diary, we also incorporated the 
intrusion triggering task, as an experimental measure of induced intrusions, into our 
study design. Although the task successfully triggered intrusions, we did not find an 
effect of cortisol administration for neither the number/distress of reported 
intrusions nor for the physiological reaction in response to the task. Thus, in our 
study we added a second independent measure of re-experiencing symptoms that 
allowed measuring psychological distress and physiological reactivity to external 
cues that symbolize the “traumatic” event. These are important re-experiencing 
symptoms, which have been neglected in previous research that focused solely on 
the relatively easy to measure intrusive memories. 
To summarize our study and the study by Ludäscher and colleagues (2015), which 
directly assessed the influence of repeated cortisol administration on intrusive 
memories in larger samples, did not find a beneficial influence of cortisol on 
intrusive re-experiencing symptoms. There seems to be a beneficial effect of 
cortisol on the prevention of PTSD for injury patients, but up to date there is no 
data supporting that this effect is mediated by the memory inhibiting effect of 
cortisol administration. Other mechanisms such as reduced pain perception due to 
the anti-inflammatory properties of cortisol might as well account for these 
findings. 
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The results of the present study do not support the beneficial effects of cortisol on 
intrusive re-experiencing symptoms in an experimental design in healthy female 
participants. Thus, our data imply that sole cortisol administration to reduce 
intrusive memories is not a useful treatment itself for PTSD patients. Future double-
blind placebo-controlled clinical trials should consider these results and should 
focus on other mechanisms, which might account for the beneficial effect of cortisol 
in some of the reported studies. 
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III STUDY 2 
Cortisol administration prevents the return of fear in a fear 
conditioning paradigm with Traumatic film clips  
Co-Authors: Johanna Lass-Hennemann, Frank Wilhelm & Tanja Michael 
1. ABSTRACT 
Cortisol is a stress hormone and potent modulator of learning and memory 
processes. If administered after learning, cortisol enhances memory consolidation. 
Yet it is unknown whether cortisol administration after fear extinction learning 
strengthens extinction memory. Extinction learning is a crucial mechanism 
underlying therapy of PTSD. The present study aims to test whether extinction 
learning can be enhanced by administering cortisol subsequent to extinction. In a 
registered, randomized, double-blind and placebo controlled trial, 50 participants 
were exposed to a differential fear conditioning paradigm with neutral faces as CS 
and traumatic film clips as US. They received either cortisol or placebo immediately 
after extinction in order to test whether long-term expression of extinction learning 
profits from cortisol administration. In accordance with our assumption, the cortisol 
group showed less ROF during a ROF manipulation (reinstatement) for US-
expectancy ratings and FPS responses than the placebo group. The results indicate 
that cortisol administration after fear extinction strengthens extinction memory and 
suggest that it might be useful to administer cortisol subsequent to a therapy 
session. 
2. INTRODUCTION 
Exposure-based therapies are effective treatment approaches for PTSD (Cusack et 
al., 2016). However, many patients still suffer from PTSD after treatment 
(Schottenbauer et al., 2008) and treatment is associated with high dropout rates 
(Schnurr et al., 2007). Fear extinction is thought to be one of the active ingredients 
I I I  S t u d y  2  | 55 
 
underlying the effectiveness of exposure (Lonsdorf et al., 2017; Michael, 2017). 
During fear extinction, a previous fear-laden stimulus is presented without aversive 
consequences. Thus, during extinction a new extinction memory trace is formed 
(Bouton, 2004) that is no longer associated with fear. However, the old fear-laden 
memory trace remains intact and extinguished fear responses can return (Todd, 
Vurbic, & Bouton, 2014; Vervliet, Craske, & Hermans, 2013). Thus, recent research 
has focussed on possible enhancers of extinction learning as they may boost the 
effectiveness of psychotherapy for PTSD. The glucocorticoid cortisol has been 
proposed as one possible enhancer of extinction learning (Bentz et al., 2010). 
Cortisol is well-known for its memory modulating effects; it enhances the 
consolidation of newly acquired memories and inhibits the retrieval of previously 
learned material (de Quervain et al., 2009a).Concerning PTSD, cortisol might be a 
useful treatment adjunct as it may enhance extinction learning by 1) inhibiting fear 
retrieval processes and 2) promoting consolidation of extinction learning. Indeed, 
animal studies have shown that glucocorticoids play an important role in successful 
fear extinction (Barrett & Gonzalez-Lima, 2004; Blundell et al., 2011; Yang et al., 
2006; Yang et al., 2007). There are only few studies on fear conditioning and cortisol 
in humans, but they also find effects of cortisol on fear conditioning processes 
(Bentz et al., 2013; Hamacher‐Dang et al., 2015; Merz et al., 2013). Importantly, in 
most of these studies cortisol was administered after extinction. Therefore, it 
remains unknown whether cortisol influenced extinction by inhibiting fear retrieval 
and/or by promoting consolidation of extinction learning. Relevantly, several clinical 
studies have shown that exogenous cortisol administration as well as high 
endogenous cortisol levels enhance the success of exposure therapy in patients 
with different anxiety disorders (de Quervain et al., 2011; Lass-Hennemann & 
Michael, 2014; Meuret et al., 2015; Meuret et al., 2016; Soravia et al., 2006) and 
PTSD (Surís et al., 2010; Yehuda et al., 2015). However, in all studies cortisol levels 
were enhanced during exposure, leaving it an open question which cortisol process 
(inhibited fear retrieval and/or better consolidation of new no-fear memory 
acquired in exposure) is linked to positive treatment outcome. In summary, 
although cortisol seems a promising psychopharmacological adjunct to 
psychotherapy for PTSD, it needs to be established whether it acts by suppressing 
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fear retrieval, by enhancing consolidation of extinction or by a combination of both 
processes. The current study aims to ascertain whether cortisol takes effect by 
strengthening the consolidation of extinction memory. If that were to be the case, 
cortisol could be administered after exposure. This would be of clinical importance, 
as the current practice of giving cortisol prior exposure contains the risk that the 
consolidation of an unsuccessful session is promoted by cortisol. Thus, in a 
registered, randomized, double-blind and placebo controlled trial, we tested our 
hypothesis that cortisol enhances the consolidation of fear extinction memory. 50 
participants underwent a differential fear-conditioning paradigm with neutral faces 
as CS and traumatic film clips as US. We chose traumatic film clips as US since they 
have higher comparability with real traumatic events than classical US like electric 
shocks. Further, recent studies demonstrated that traumatic films are powerful US 
in conditioning studies (Streb et al., 2016; Wegerer et al., 2013). The paradigm 
consisted of several phases: acquisition (day 1), extinction (day 2), and a ROF 
manipulation with reinstatement followed by a ROF test (day 3). Importantly 
cortisol/placebo was administered solely subsequent to extinction. Primary 
outcome measure was the fear response during the ROF manipulation and test. 
Fear was assessed on both a physiological level (FPS, SCR) and a subjective level 
(expectancy and valence ratings). We expected the cortisol group to exhibit lower 
fear responses during reinstatement than the placebo group. 
3. MATERIAL AND METHODS 
3.1 Participants and general procedure 
73 healthy, non-smoking students (44 females) with a BMI within the normal range 
(females: 18.5 – 26 kg/m2, males: 19 – 27 kg/m2) participated in this study. Only 
women with regular use of monophasic oral contraceptives3 were included to 
minimize the influence of menstrual cycle phase on hormonal status. Exclusion 
criteria were a history of systematic or oral cortisol therapy, any medication and/or 
drug intake, current mental and/or physical illness, previous physical and/or sexual 
abuse, pregnancy and lactation, and participation in a pharmacological study within 
                                                     
3
 Except of contraceptives containing drosperinone (e.g. Yasmin, Yasminelle or Petibelle), inhibiting 
the endogenous cortisol synthesis (Genazzani, Mannella, & Simoncini, 2007). 
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the past month. Participants were instructed to refrain from physical exercise, 
alcohol, and smoking during the experimental days as well as from caffeine 
beverages three hours prior to the experimental sessions. All participants provided 
written informed consent and received 50 Euros as financial reimbursement. The 
study was registered in the German Clinical Trial Register (DRKS00010684) and was 
approved by the responsible local ethics committee. 
Participants were randomly assigned to the cortisol or the placebo group, filled out 
several questionnaires prior to and at the end of testing and assessed intrusive 
memories during the experimental days which are reported elsewhere. Focus of the 
current study is the conditioning procedure. 
3.2 Conditioning procedure 
The differential fear conditioning task took place on three consecutive days: 
Acquisition of conditioned fear on day 1, extinction learning and cortisol/placebo 
intake on day 2, reinstatement and ROF test on day 3. Each conditioning phase 
started with nine startle habituation trials, pre-ratings of US-expectancy and 
valence of the CSs, followed by a randomized order of trials of each CS-type 
(reinforced CS+ presented with a traumatic film clip (US), CS- presented with a 
neutral film clip as control condition (CC); unreinforced CS+/CS- never compared 
with US/CC). During each trial the startle probe was presented 7 s after stimulus 
onset and inter-trial intervals (ITIs) varied between 15 and 20s. US-expectancy and 
valence for the CSs were rated halfway through and at the end of each phase. To 
control for diurnal variations in cortisol levels, all experimental sessions were 
scheduled between 1 p.m. and 6 p.m.. For detailed instructions see supplementary. 
Day 1: Acquisition. During acquisition, CS+/CS- were each presented 12 times for 
eight seconds, reinforcement rate was 75%. Immediately after CS presentation, the 
US/CC followed (see Figure9). Participants were asked to rate the US-expectancy 
and valence of the CSs prior to (pre-acq), halfway through and at the end of 
acquisition (mean-acq)4. Finally, participants were told that the most burdening part 
                                                     
4
 The behavioral ratings halfway through and at the end of the conditioning phases were aggregated 
to one mean value in each phase, which is further included in the analysis. 
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of the study was over and that only one more traumatic film clip would be 
presented over the course of the subsequent sessions. 
 
Figure 9. Reinforced conditioning trials. CS duration was 8s. Startle probe was presented 7s after CS 
onset. At CS offset either an aversive film clip (US) or a neutral film clip as control condition (CC) was 
presented for 16s. 
Day 2: Extinction and cortisol/placebo administration. To ensure memory 
consolidation of the acquired fear association (Dudai, 2004), the extinction 
procedure took place 24 hours after acquisition. CS+/CS- were each presented six 
times for eight seconds and were never followed by the US. US-expectancy and 
valance ratings were again assessed before (pre-ext), half-way through and at the 
end of extinction (mean-ext)1. Following extinction, participants received either 
cortisol or placebo. As a manipulation check participants provided 2 saliva samples: 
one sample prior to pill intake (pre-treat) and one sample 30 minutes after 
cortisol/placebo administration (post-treat). 
Day 3: Reinstatement and ROF test. This phase took place 24 hours after 
cortisol/placebo intake. Initially participants rated US-expectancy and valence of the 
CSs (pre-ROF). After that one US was presented (reinstatement). Subsequently, ROF 
test was realized with the presentation of CS+/CS- (never followed by US). Each 
CS+/CS- was presented six times for eight seconds. Half-way through and at the end 
of ROF test, participants’ rated US-expectancy and valence of the CSs (mean-ROF)1. 
Further, they provided 5 saliva samples to assess cortisol levels during 
reinstatement procedure: one sample upon arrival (arrival-rei), one sample prior to 
reinstatement (pre-rei), one sample immediately after reinstatement test (post-rei) 
and two more at intervals of 15 minutes (+15min, +30min). 
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3.3 Stimuli 
Conditioned stimuli. The CS were four different frontal view images of female or 
male Caucasian faces with a neutral facial expression (Radboud Faces Database 
(RaFD), no.23, no.31, no.33, no.61)5. The pictures were matched for valence (f: M1 
= 50.35, M2 = 50.76; m: M1 = 51.67, M2 = 48.30), colour and picture quality (525 x 
675 pixel). They were presented against a black screen, counterbalanced between 
participants and within the subgroup of females and males. 
Unconditioned stimuli/control condition. Nine traumatic 16 second film clips 
displaying extreme sexual or physical violence (e.g., rape, torture) were used as 
unconditioned stimuli (US), which were presented in a pseudorandomized order. 
The CS- was followed by neutral film clips, which served as a CC. Neutral film clips 
were matched to the traumatic film clips concerning the number of people 
interacting with each other and film quality (1920x1080 pixels). All film clips 
(traumatic and neutral) were generated from different commercial available feature 
films and some were already successful employed in a different study (see 
supplementary material). 
3.4 Cortisol/placebo administration 
Participants received 30 mg cortisol (3 pills of hydrocortisone 10mg; Jenapharm) or 
visually identical placebos (3 pills of P Tabletten Wiss 7 mm, Winthrop) immediately 
after extinction learning. The dose of cortisol was based on previous studies 
examining cortisol effects in fear conditioning paradigms (Meir Drexler et al., 2015; 
Merz et al., 2013; Merz et al., 2012). 
3.5 Behavioural outcome measures 
Expectancy ratings. We assessed CS-specific US-expectancy with the question “How 
much do you expect the next presentation of this face to be followed by an aversive 
film clip?” using a visual analogue scale ranging from “very low expectancy” to “very 
high expectancy (0-100). 
                                                     
5
 To select these faces, in a pilot study 46 participants rated 40 neutral faces (20 female) from the 
RaFD regarding their valence using a visual analogue scale ranging from 0 (not at all unpleasant) to 
100 (very unpleasant). 
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Valence ratings. To assess the valence of the CS, participants indicated the 
unpleasantness of CS+/CS- on a visual analogue scale ranging from “not at all 
unpleasant” to “very unpleasant” (0-100). 
3.6 Physiological outcome measures 
Physiological data were recorded by ActiveTwo Software (BioSemi, Amsterdam, 
Netherlands) and continuously digitized with a sample frequency of 2048 Hz per 
channel using a 24-bit A/D converter and further analysed with ANSLAB version 2.6 
(Blechert et al., 2016). For outlier analysis, SCR and FPS were z-standardized. 
Outliers were defined for each participant separately (Z > 3). Outliers and missing 
data due to technical difficulties were replaced by the linear trend at point (Kindt, 
Soeter, & Vervliet, 2009; Kunze, Arntz, & Kindt, 2015; Sevenster, Beckers, & Kindt, 
2012) (see supplementary). 
FPS. Startle response was measured from orbicularis oculi electromyogram and 
amplitude values were calculated relative to the baseline of the signal 50ms before 
the trigger onset. FPS responses were normalized by T-transformation. Four 
participants showed less than 70% valid trials and were excluded from further 
analysis regarding FPS. 
SCR. We calculated SCR by subtracting the average pre-CS baseline SCL (-2 to 0 s 
relative to CS onset) from the maximum CS SCL (0 to 6 s relative to CS onset) and 
normalized SCR data by using the natural logarithm of 1+SCR (in µS). 
Saliva samples. Saliva samples were collected using Salivette tubes (Saarstedt) and 
kept at -20°C until analysis at the cortisol laboratory of the University of Trier (for 
details on biochemical analysis, see Dressendörfer, Kirschbaum, Rohde, Stahl, & 
Strasburger, 1992). 
3.7 Statistical analysis  
Data were analysed with SPSS (IBM SPSS Statistics 21). The alpha level was set at 
p<0.05 and Greenhouse-Geisser corrected p-values are reported if the assumption 
of sphericity was violated. Effect sizes are reported as partial η2.  
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4. RESULTS 
4.1 Participants characteristics  
11 participants discontinued the study and 12 participants did not acquire CS-US 
contingency and were excluded from further analysis6 (see also Kunze et al., 2015). 
Our final sample consisted of 50 participants, 25 per group (for participants` 
characteristics see table 3).  
Table 3. Participants‘ characteristics in the cortisol and the placebo group 
 Cortisol Group (14 ♀)   
M (SD)  
Placebo Group (11 ♀) 
M (SD) 
p-value 
Age 24.60 (4.33) 23.88 (3.00) 0.498 
BMI 22.11 (2.25)  22.48 (2.46) 0.576 
BDI 3.71 (4.86) 4.64 (5.16) 0.519 
STAI-T 32.88 (8.52) 34.68 (10.89) 0.522 
BMI: Body Mass Index, BDI: Becks Depression Inventory, STAI-T: State-Trait-Anxiety-Inventory, p: p-
value of a two-sample t-test between the two groups. Baseline questionnaires (BDI and STAI-T) were 
filled in prior to the first experimental session. 
4.2 Startle Habituation 
The habituation of the startle response at the beginning of each conditioning phase 
was tested with a mixed design ANOVA with the factors Trial (1st, 2nd, … , 9th) and 
Group (cortisol, placebo). All participants habituated to the startle probe prior to 
acquisition (main effect of Trial p<.001), extinction (main effect of Trial p<.001) and 
reinstatement (main effect of Trial p<.001) in absence of any group-related effects 
(all ps>.154). 
4.3 Manipulation check 
Cortisol treatment. A mixed design ANOVA with the factors Time (pre-treat, post-
treat) and Group (cortisol, placebo) revealed elevated cortisol levels after cortisol 
intake in the cortisol group as compared to the placebo group (Time: p.<001, 
Time*Group: p.<001). 
                                                     
6
 Note that – for the excluded participants – there was also no evidence for implicit awareness of CS-
US contingency neither for FPS (no main effect of CS-Type: p=.264, non-significant CS-Type*Time: 
p=.714) nor for SCR (no main effect of CS-Type: p=.555, non-significant CS-Type*Time: p=.622). 
I I I  S t u d y  2  | 62 
 
4.3.1 Acquisition 
Behavioural outcome measures. Fear acquisition was tested by conducting mixed 
design ANOVAs with the factors CS-Type (CS+, CS-), Time (pre-acq, mean-acq) and 
Group (cortisol, placebo). Analysis for US-expectancy revealed effects for Time 
(p<.011, η2=.13), CS-Type (p<.001, η2=.69) and a Time*CS-Type interaction (p<.001, 
η2=.78), but no interaction effects with the group factor (all ps>.095) showing 
successful acquisition as US-expectancy for the CS+ increased from pre- to mean-
acquisition in both groups. For valence the effects CS-Type (p<.000, η2=.36), Time 
(p<.002, η2=.118), CS-Type*Time (p<.000, η2=.48), CS-Type*Group (p<.004, η2=.163) 
and CS-Type*Time*Group (p<.010, η2=.13) were significant. Planned comparison 
showed a baseline difference regarding the CS- (e.g., lower CS- ratings in the 
placebo group) prior to acquisition (p<.000)7. However, importantly at the end of 
acquisition both groups evaluated the CS+ and CS- in the same way (all ps.<182) 
showing successful fear acquisition for valence ratings. 
Physiological outcome measures. To test successful acquisition, we conducted 
mixed design ANOVAs with the factors Group (cortisol, placebo), CS-Type (CS+, CS-) 
and Time (early, late). Analysis for FPS revealed effects for CS-Type (p<.003, η2=.18), 
for Time (p<.001, η2=.42), but no effects with the group factor (all ps>.085), showing 
successful fear acquisition for FPS in both groups. SCR analysis displayed a main 
effect for CS Type (p<.001, η2=.19), but no effects for Time (p=.331), for CS-
Type*Time (p=.379) and no interaction with the group factor (p>.064). This 
indicates successful fear acquisition for SCR in both groups, which was already 
evident in the early acquisition phase (first 6 trials). 
4.3.2 Extinction 
Behavioral outcome measures. To test for successful fear extinction, we conducted 
mixed design ANOVAs with the factors CS-Type (CS+, CS-), Time (pre-ext, mean-ext) 
and Group (cortisol, placebo). Analysis for US-expectancy showed effects for Time 
(p<.001, η2=.21), for CS-Type (p<.000, η2=.8) and Time*CS-Type (p<.000, η2=.39), but 
no interaction with the group factor (all ps>.121), e.g., US-expectancy for the CS+ 
                                                     
7
 Descriptive data of the CS- in the acquisition phase: cortisol group pre-acq = 40.81 (23.23), post-acq 
= 23.78 (22.55); placebo group pre-acq = 15.43 (18.6), post-acq = 16.09 (17.25)  
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decreased from beginning to end of extinction in both groups. Regarding valence 
ratings analysis revealed no effects for time (p=.499), nor for CS-Type*Time (p=.316) 
and no interaction with the group factor (all ps<.126), showing no extinction effect 
for valence ratings in both groups. 
Physiological outcome measures. To test for successful fear extinction, we 
conducted mixed design ANOVAs with Group (cortisol, placebo) as between subject 
factor, and CS-Type (CS+, CS-) and Time (early, late) as within-subjects factors. 
Analysis for FPS revealed an effect for time (p<.001, η2=.54), but not for CS-Type 
(p=.126) and not for CS-Type*Time (p=.21), showing successful extinction learning 
as FPS was no longer differential and decreased from beginning to the end of 
extinction. Note that the placebo group showed a marginally significant stronger 
extinction response than the cortisol group (CS-Type*Time*Group: p=.057), 
indicating lower fear responses at the end of extinction in the placebo group 
compared to the cortisol group. SCR analysis found no effects for CS-Type (p=.247), 
for Time (p=.101), for Time*CS-Type (p=.648) and no interaction with the group 
factor (all ps>.129). This indicates successful fear extinction for SCR in both groups. 
However, as for the acquisition phase, successful extinction was already evident in 
the early extinction phase (first 6 trials). 
4.4 Tests of assumption – ROF test  
Behavioral outcome measures. To test our main hypothesis that cortisol 
administration leads to a lower ROF, we conducted mixed design ANOVAs with the 
factors CS-Type (CS+, CS-), Time (pre-ROF, mean-ROF) and Group (cortisol, placebo). 
Regarding US-expectancy effects for CS-Type (p<.001, η2=.64), CS-Type*Group 
(p<.002, η2=.18) and Time*CS-Type*Group (p<.001, η2=.29) were significant. US-
expectancy for the CS+ decreased from pre to mean ratings in the cortisol group, 
whereas in the placebo group US-expectancy for the CS+ remained high. 
Additionally, US-expectancy was no longer differential in the cortisol group as 
compared to the placebo group. In accordance with our assumption, in the cortisol 
group reinstatement led to less ROF indicated by lower levels of US-expectancy as 
compared to the placebo group (see Figure 10A). Analysis for valence ratings point 
in the same direction with marginal significant effects for Time (p=.071) and CS-
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Type*Group (p=.061). This indicated that during ROF test the cortisol group 
evaluated the CS+ more positive than the placebo group although, no extinction 
was observed (see Figure 10B). 
 
Figure 10. (A) US-Expectancy and (B) valence ratings on CS+ and CS- during test of reinstatement for 
the cortisol and placebo group. 
Physiological outcome measures. To examine if reinstatement led to a ROF in 
physiological measures and if this was moderated by cortisol administration, we 
conducted mixed design ANOVAs with the factors CS-Type (CS+, CS-), Time (late 
extinction, early and late reinstatement) and Group (cortisol, placebo). With regard 
to FPS analysis revealed significant effects for CS-Type (p<.020, η2=.13), Time 
(p<.023, η2=.09) and CS-Type*Time*Group (p<.004, η2=.13) (see Figure 11A). As 
expected, only the placebo group showed significant ROF as indicated by an 
increased FPS for the CS+ from late extinction to reinstatement (p<.026). In 
addition, the cortisol group showed reduced FPS towards the CS+ from late 
extinction to late reinstatement (p<.017). Furthermore, the cortisol group did no 
longer show differential FPS (all ps<.15), whereas the placebo group did show a 
trend towards differential FPS at the beginning of ROF test (p=.059). Regarding SCR, 
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analysis did not find effects for Time (p=.159), for CS-Type*Time (p=.115) and also 
no interaction with the group factor (all ps>.07), indicating that reinstatement did 
not lead to a ROF in both groups (see Figure 11B). 
 
Figure 11. (A) Startle Response to CS+ and CS- at the end of extinction and during reinstatement test 
for the cortisol and placebo group. (B) Skin conductance response to CS+ and CS- at the end of 
extinction and during reinstatement test for the cortisol and placebo group. 
Cortisol levels during ROF test. A mixed design ANOVA with the factors Time (arrival, 
pre, +0min, +15min and +30min) and Group (cortisol, placebo) yielded effects for 
Time (p<.000) and for Time*Group (p<.038), indicating elevated cortisol levels in the 
placebo group compared to the cortisol group with a naturally decrease of cortisol 
concentration after ROF test. 
5. DISCUSSION 
This study aimed to examine if cortisol administration facilitates the consolidation 
of extinction learning in a new fear conditioning paradigm using traumatic film clips 
as US. We expected the cortisol group to show a lower ROF during ROF test than 
the placebo group. In accordance with our assumption the cortisol group showed 
less ROF as indicated by a lower US-expectancy for the CS+, a trend towards a more 
positive evaluation of the CS+ and attenuated FPS in the ROF test as compared to 
the placebo group. Further, cortisol concentrations during ROF test were lower in 
the cortisol group than in the placebo group, indicating a reduced stress response to 
ROF manipulation in the cortisol group. Thus, our results support the assumption 
that cortisol facilitates the consolidation of extinction learning (e.g., Yehuda et al., 
2015). Our results are also in line with studies combining cortisol and exposure 
therapy showing enhanced therapy outcomes for patients with different anxiety 
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disorders (de Quervain et al., 2011; Lass-Hennemann & Michael, 2014; Meuret et 
al., 2015; Meuret et al., 2016; Soravia et al., 2006; Soravia et al., 2014) and PTSD 
(Surís et al., 2010; Yehuda et al., 2015). Importantly, our results extend these 
findings by giving new insights on which cortisol process is linked to these positive 
treatment outcomes as our results clearly show that cortisol leads to an enhanced 
consolidation of extinction learning. Furthermore, our data indicate that cortisol 
also has a treatment enhancing effect if administered after treatment, which is of 
high clinical relevance as clinicians will only want to enhance learning in successful 
treatment sessions. However, it has to be noted that criteria for “successful” 
sessions are still under debate. 
Further support that enhancing the consolidation of extinction learning by cortisol 
seems to be a more likely mechanism by which cortisol acts upon exposure therapy 
is provided by two recent studies showing sole cortisol administration does not 
inhibit the retrieval of intrusive memories (Ludäscher et al., 2015, Graebener, 
Michael, Wilhelm & Lass-Hennemann, 2017). However, to test which role retrieval 
inhibition effects of cortisol play for the enhancement of exposure therapy further 
studies are needed. In a first step, experimental studies should compare effects of 
a) cortisol administration prior to extinction learning with the effects of b) cortisol 
administration after extinction learning. In a second step, these should be 
transferred to clinical studies to test whether: a) cortisol administration after 
therapy has a beneficial effect on therapy outcome and b) whether cortisol 
administration after therapy is more or less beneficial than cortisol administration 
prior to therapy. In addition, future studies should employ other measures of the 
strength of extinction memory such as generalizability or renewal effects as they 
are important outcome measures especially with regard to psychotherapy. 
We were able to show successful fear acquisition, fear extinction and ROF with our 
new conditioning paradigm using traumatic film clips as US. Thus, with this 
paradigm we developed a high ecological valid model for assessing learning and 
memory processes in the development and therapy of PTSD. Even though our 
results nicely showed fear acquisition, extinction and ROF in the two groups, there 
were some inconsistencies in the results. First, there was no extinction learning for 
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valence of the CS. However, this is in line with previous findings, showing that 
evaluative learning is very resistant to extinction (Blechert, Michael, Williams, 
Purkis, & Wilhelm, 2008; Vansteenwegen, Francken, Vervliet, de Clercq, & Eelen, 
2006). Second, we did not find a group difference regarding SCR during ROF test. 
One possible explanation is an interfering influence of the startle probe. The SCR is 
a rather slow physiological signal and needs some time to recover to clearly 
illustrate a new response. SCR was calculated upon 1-6s after CS onset and the 
startle probe was presented at 7s, which could have had an interfering influence on 
the SCR over the course of time. In order to make a statement regarding the 
influence of cortisol on SCR further studies should assess SCR without FPS. 
Some limitations of our study have to be taken into account. Our sample consisted 
of healthy students without any psychopathology. Thus generalizability to PTSD 
patients may be limited. Furthermore, our female participants took oral 
contraceptives and it is known that emotional memory formation in general 
(Nielsen, Barber, Chai, Clewett, & Mather, 2015) and cortisol effects on memory 
(Merz et al., 2012) differ between free-cycling females and females taking hormonal 
contraceptives. Therefore, the results might not easily be generalized to free-cycling 
women. Thus, future preclinical research as well as clinical studies in PTSD patients 
should compare the effects of cortisol administration between free-cycling female 
participants and those who use hormonal contraceptives. 
To summarize, our results are in line with previous assumptions that cortisol is a 
useful treatment adjunct for exposure therapy (Bentz et al., 2010; Yehuda et al., 
2015). We showed for the first time that cortisol takes effects by strengthening the 
consolidation of extinction memory. This offers the opportunity to administer 
cortisol after an exposure session and to avoid the risk of consolidating an 
unsuccessful treatment session. . Further, the results indicate that cortisol may be a 
quite strong therapy enhancer as it influences both the explicit knowledge about 
the fear association and the implicit conditioned response, whereas most previous 
studies investigating pharmacological therapy enhancer showed an effect on 
explicit knowledge (e.g., Kindt et al., 2009). 
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To conclude, our results emphasize the role of cortisol with regard to long-term 
consolidation of new extinction memory trace. Accordingly, our results may have 
important implications for the employment of cortisol in the treatment of PTSD and 
other anxiety disorders. 
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IV GENERAL DISCUSSION 
The global aim of this thesis was to systematically investigate the dual influence of 
cortisol on emotional learning and memory processes in controlled experimental 
settings in interest of improving treatment for PTSD. The GC cortisol is well-known 
for its memory-modulating effects (for a review, see Het et al., 2005). If 
administered after a learning session, it facilitates consolidation processes; if 
administered prior to a recall test, it inhibits retrieval of previously learned material. 
This is especially evident for emotional material (e.g., Kuhlmann et al., 2005). In 
addition to these findings from basic research, clinical studies have shown 
administration of GCs may prevent the development of PTSD (Delahanty et al., 
2013; Schelling, 2002; Schelling et al., 2001; Schelling et al., 2004; Schelling et al., 
1999) and reduces cardinal symptoms of chronic PTSD (Aerni et al., 2004). These 
findings are attributed to the impairing effect of GCs on memory retrieval. Further 
beneficial effects of cortisol, evident from studies combining cortisol administration 
or endogenous elevated cortisol levels with exposure therapy sessions, highlight 
that, besides the impairing effect on retrieval, GCs also have an enhancing effect on 
consolidation (de Quervain et al., 2011; Lass-Hennemann & Michael, 2014; Soravia 
et al., 2006; Surís et al., 2010; Yehuda et al., 2014). However, since cortisol levels 
were increased prior to exposure sessions in the above mentioned studies, it is not 
possible to discern whether the therapy-enhancing effect of cortisol is due to 
impaired retrieval of traumatic/fear memories or to strengthened consolidation of 
extinction memory or to a complex interaction of both mechanism. This thesis 
attempted to investigate the issue with two studies examining 1) the inhibiting 
effect of GCs on retrieval of trauma memories and 2) the enhancing effect of GCs on 
consolidation processes of fear extinction. 
The results of both studies carried out in this thesis have been discussed in detail in 
their respective chapters (see Chapter II, section 4 and chapter III, section 4). Thus, 
the scope of the general discussion is to provide a summary and integration of the 
major findings obtained in this thesis regarding their clinical implications. 
Furthermore, this will be discussed from a broader perspective in the context of 
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current theoretical frameworks and recent findings. Following, some general 
strengths and limitations of the present work will be elucidated, including 
implications for further research. Finally, a conclusion will be drawn. 
1. SUMMARY, INTEGRATION AND CLINICAL IMPLICATIONS OF FINDINGS 
1.1 Study 1 - Repeated cortisol administration does not reduce intrusive 
memories – a double blind placebo controlled experimental study 
The first study of this thesis aimed to examine if repeated cortisol administration 
reduces experimentally induced trauma memories in healthy individuals by using 
the trauma film paradigm. In a double blind design, participants were exposed to a 
traumatic film clip and then randomly assigned to receive either a dose of cortisol 
or placebo for three days following trauma exposure. Participants were asked to 
monitor their intrusive memories of the traumatic film using an electronic diary. In 
addition, we assessed intrusive memories in the laboratory with the ITT designed to 
model daily life situations in which trauma survivors might undergo intrusive 
memories and recognition memory with an old/new paradigm. We could validate 
the trauma film paradigm as participants’ experienced heightened physiological 
arousal as well as anxiety during the trauma film and reported having, on average 
3.2 (SD 2.1) intrusive memories within the three days following the traumatic 
experience. However, contrary to the main prediction, repeated cortisol 
administration neither inhibited ambulatory intrusive memories throughout the 
treatment days. Further, it did not have an impact on provoked intrusions in the 
laboratory setting using the ITT, although it successfully provoked intrusions in both 
groups. In the aftermath of the ITT, participants reported on average of 2.4 (SD 2.2) 
intrusive memories with a moderate distress of 3.1 (SD 2.8) on a visual analog scale 
ranging from 0 (no distress at all) to 10 (very high distress). Furthermore, the 
cortisol group did not show a diminished performance in a recognition task 
assessing trauma-related content compared to the placebo group. Thus, cortisol 
administration did not effectively impair retrieval of experimental trauma 
memories. 
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At first sight these findings seems to be in contrast to studies reporting beneficial 
effects of cortisol administration on PTSD symptoms. However, some studies 
focused on the prevention of PTSD in physically injured patients and administered 
either high doses of cortisol to intensive care unit patients for example after septic 
shock (Schelling et al., 2001; Schelling et al., 2004; Schelling et al., 1999) or repeated 
low doses to injured victims within 12 hours of hospital admission and over the 
following 10 days (Delahanty et al., 2013). Whether these effects are due to an 
inhibition effect of cortisol on trauma memories or other mechanism remain 
unsolved. Other studies reporting positive effects of cortisol on PTSD symptoms 
(e.g., Yehuda et al., 2015) combined cortisol and exposure therapy and may have 
targeted different memory processes than the first study as these studies increased 
cortisol levels prior to treatment sessions. 
With regard to studies explicitly investigating the influence of cortisol 
administration on the retrieval of intrusive memories; our findings are in line with 
two recent clinical studies. A study by Ludäscher and colleagues (2015) reported no 
evidence for differential dose effects of hydrocortisone on traumatic memory 
retrieval in female patients with complex post-traumatic stress disorder. In addition, 
a study by Suris et al. (2010) did not find an impact of cortisol administration on the 
intrusion subscale of the IES-R, but on the general symptom load. 
Furthermore, we found a reduced CAR on the second and third treatment day in the 
cortisol group as compared to the placebo group, although cortisol administration 
led to a significantly increased diurnal cortisol profile. This decline in morning 
cortisol may be explained by the negative feedback function of cortisol in healthy 
individuals, which regulates cortisol synthesis to protect the body from persistent 
elevated cortisol levels (Karow & Lang-Roth, 2012; Mutschler et al., 2008). However, 
PTSD patients often show a dysfunctional cortisol synthesis (Yehuda et al., 1996). 
Thus, the question arises how the CAR in particular and the cortisol synthesis in 
general would be affected by a prolonged cortisol administration. One could 
assume that the negative feedback function in PTSD patients is not as reactive as in 
healthy controls and thus, other side effects as in healthy individuals may occur. 
This has to be taken into account when administering cortisol. 
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In conclusion, the findings of study 1 did not support the beneficial effects of 
cortisol administration in the aftermath of a traumatic event on re-experiencing 
symptoms. Further, these results indicated that cortisol administration alone seems 
not to be an effective treatment option for PTSD, leaving it an open question if 
cortisol administration in combination with exposure therapy might be beneficial. 
This open question motivated the second study, which aimed to investigate the role 
of cortisol on consolidation processes. 
1.2 Study 2 - Cortisol administration prevents the return of fear in a fear 
conditioning paradigm with traumatic film clips 
In response to the findings of the first study, the second study aimed to examine 
which mechanism might account for the beneficial cortisol effects on PTSD 
treatment found in other studies. Thus, study 2 focused on the enhancing effect of 
cortisol on consolidation and explicitly tested the hypothesis that cortisol facilitates 
consolidation of extinction learning, which would be additionally clinical relevant as 
the current studies administering cortisol prior to a treatment session contain the 
risk of promoting consolidation of an unsuccessful therapy session. We employed a 
new experimental paradigm using fear conditioning with neutral faces as CS and 
traumatic film clips as US to have higher comparability with natural occurring 
traumatic events than classical US like e-shocks. Healthy participants were 
completed to a differential fear conditioning paradigm, including acquisition, 
extinction learning and reinstatement, on three consecutive days. Immediately after 
extinction learning, a crucial mechanism of exposure therapy participants received 
either a dose of cortisol or placebo. Our main outcome measure was fear, assessed 
with US-expectancy, valence ratings of the CSs, FPS and SCR. Results revealed that 
all participants demonstrated successful fear acquisition and extinction. In the 
reinstatement phase the cortisol group demonstrated a reduced ROF compared to 
the placebo group. This was evident by lower US-expectancy for the CS+, a 
marginally less negative evaluation of the CS+, as well as an attenuated FPS. 
Thus, study 2 supports the hypothesis that cortisol enhances consolidation of 
extinction learning and thereby strengthens extinction memory. These results are in 
line with the existing findings (de Quervain et al., 2011; Lass-Hennemann & Michael, 
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2014; Soravia et al., 2006; Surís et al., 2010; Yehuda et al., 2014) and, more 
importantly, they give new insights into the mechanism responsible for the 
reported beneficial effects. The results clearly showed that the extinction enhancing 
effect of cortisol seems to be a more likely mechanism by which cortisol acts upon 
exposure therapy. Further support for this assumption is provided by the recent 
study from Ludäscher and colleagues (2015) and from study 1 (Graebener et al., 
2017), showing sole cortisol administration does not inhibit the retrieval of intrusive 
memories. However, further experimental and clinical studies in PTSD patients are 
needed that systematically investigate the different effects of cortisol 
administration before and after (exposure) treatment to estimate which role 
retrieval inhibition effects of cortisol play for the enhancement of exposure therapy. 
In addition, the data of study 2 suggest that cortisol could be administered after a 
treatment session, allowing only promoting successful treatment sessions, which is 
of high clinical relevance. Whether, this is more effective than administration prior 
to a treatment session remains unclear and needs to be tested in further 
experimental studies. 
Notably, the cortisol manipulation affected both memory systems the declarative 
memory system with the explicit knowledge about the fear association (i.e., US-
expectancy) and the implicit memory system including the conditioned responses 
(i.e., FPS). A previous study investigating propranolol as a pharmacological therapy 
enhancer only showed an effect on the declarative memory system (e.g., Kindt et 
al., 2009). Propranolol was administered before memory reactivation in a 
differential fear conditioning paradigm including acquisition, memory reactivation, 
and extinction followed by a reinstatement. The conditioned fear response was 
assessed by FPS and shock-expectancy ratings. The FPS was eliminated by 
propranolol, but there was no influence on the expectancy ratings. The authors 
assume that propranolol selectively acts in the amygdala during emotional memory 
formation resulting in deconsolidation of the fear memory trace while leaving the 
declarative memory in the hippocampus inviolate (Kindt et al., 2009). In our study 
US-expectancy ratings (explicit knowledge) and the FPS (implicit and 
unconsciousness fear response) were affected by cortisol administration, which 
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emphasizes the role of cortisol as treatment enhancer. Thus, the results of study 2 
indicate that cortisol may be a quite strong therapy enhancer and should be 
therefore prioritized in future research regarding treatment enhancer. 
It is important to note that PTSD is a severe mental disorder with additional very 
stressful and complex symptoms, which can also have an influence on the therapy 
process. There are several risk factors influencing the development and persistence 
of PTSD as well as the therapy process and thus, might have further impact on 
treatment outcome. Consequently, they might also interact in a complex way with 
cortisol influences during the therapeutic process. Therefore, these risk factors will 
be highlighted throughout the next section. 
2. DISCUSSION OF FACTORS POSSIBLY RELEVANT FOR THE TREATMENT OF PTSD 
2.1 Risk factors of PTSD 
The fact that not all individuals who experience a traumatic event develop a PTSD 
elucidates (in addition to the event factors) the relevance of individual factors 
before, during and after the trauma affecting psychological well-being and potential 
development of psychopathology. Various studies emphasize psychological as well 
as physiological factors in the persistence of PTSD on an individual level (e.g., 
Brewin, Andrews, & Valentine, 2000; DiGangi et al., 2013; Ehring, Ehlers, Cleare, & 
Glucksman, 2008; Koenen, Stellman, Stellman, & Sommer, 2003; Ozer, Best, Lipsey, 
& Weiss, 2003; Schnurr, Lunney, & Sengupta, 2004). 
2.1.1 Psychological risk factors of PTSD 
Regarding psychological factors, different studies have found different risk factors 
prior to (pre), during (peri) and after (post) the trauma for the development and 
maintenance of PTSD. Peri- and post-traumatic factors predicting PTSD and its 
symptoms include lack of social support, additional stressors after trauma (for a 
meta-analysis, see Brewin et al., 2000), perceived life threat during trauma, peri-
traumatic emotional responses, and, in particular, dissociation during trauma (Ozer 
et al., 2003). However, factors prior to trauma, such as own or familial history of 
psychopathology, abuse in childhood and previous traumatic experiences, have also 
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been shown to have predictive effects on PTSD development, albeit with smaller 
effect sizes (Brewin et al., 2000; Ozer et al., 2003). In addition to these factors, a 
range of cognitive and behavioural strategies, which are inter alia used by the 
traumatized individual to control the current threat, are thought to contribute to 
the development and persistence of PTSD (Ehring, Ehlers, & Glucksman, 2008). 
These predictors are derived from Ehlers and Clark’s model (2000) and include 
cognitive processing during the trauma, trauma-specific memory characteristics, 
negative appraisal of the trauma and its consequences, safety behaviours, 
rumination, thought suppression and continuing dissociation (for detailed 
information on these factors contributing to PTSD see chapter I, section 1.4) (Ehring, 
Ehlers, & Glucksman, 2008). 
All of these aspects should be considered when setting up predictive models to 
investigate the course of trauma and fear memories and especially when examining 
treatment enhancers. Thus, from a clinical perspective it is highly relevant to reveal 
factors that predict or influence treatment outcome since not all patients benefit 
from exposure therapy (for more detail see chapter I, section 2). Thus, so far, some 
risk factors have also been identified as predictors of treatment outcome, e.g., 
studies showed that dissociation (Hagenaars, van Minnen, & Hoogduin, 2010; 
Resick, Suvak, Johnides, Mitchell, & Iverson, 2012) and depression (Hagenaars et al., 
2010) have an impact on the efficacy of PTSD treatment. All over, risk factors of 
PTSD not only contribute to the development and maintenance of the disorder but 
also might influence treatment outcome and should thus be considered in 
intervention studies. 
However, the above mentioned factors have not been in the focus of the current 
thesis since both of the included studies tested healthy participants and used 
experimental paradigms to induce PTSD-like symptoms in study 1 and to determine 
fear extinction in study 2. Indeed, there are studies showing that some of these 
factors not alone influence “real” PTSD symptoms but also contribute to analogous 
symptoms in healthy participants. For example, a recent study using the trauma film 
paradigm showed state rumination together with state anxiety and trait dissociation was 
predictive for PTSD-like symptoms (Holz et al., 2017). Accordingly, another study 
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revealed that several pre-existing individual factors such as trait anxiety, depression 
and trait dissociation in addition to increased anxiety during and after the 
distressing film, have been predictive for the development of intrusive memories 
(Laposa & Alden, 2008). 
In addition it is important to note, that even though the studies carried out in this 
thesis did not incorporate these factors in the data analysis, they did control for 
some of these factors. Prior to each experiment, participants underwent a semi-
structured interview assessing medical conditions and previous traumatic 
experiences and filled out different questionnaires capturing symptoms of trait-
anxiety, depression and rumination. Participants included in the final samples of 
both studies did not show any clinically relevant results regarding these factors and 
no differences were observed between the cortisol and placebo groups in either 
study. 
While it is essential to protect participants in experimental analogue studies, there 
are further some scientific considerations regarding how the effect of these 
psychological risk factors might be investigated in different sample populations. For 
example, depression symptoms commonly co-occur with PTSD, but it is not clear 
whether they predispose individuals to PTSD symptoms or whether they stem from 
the traumatic experiences (e.g., Yehuda, 2002). Importantly, there is evidence of co-
morbid major depression influencing cortisol effects (Wingenfeld et al., 2013). 
Another candidate factor is rumination, as it plays an important role in predicting 
the development and persistence of PTSD, and is associated with intrusive 
memories (Ehlers, Ehring, & Kleim, 2012), even in analogue studies (Holz et al., 
2017). To further investigate both trait and peri-traumatic dissociation and state 
rumination could have been gainful regarding intrusive memory formation in study 
1, as findings have revealed an association of these three factors with development 
of intrusive memories (Ehlers & Clark, 2000; Ozer et al., 2003). Last but not least, 
findings have suggested that the extent of processing of threat-related stimuli is 
crucially dependent on participants’ anxiety levels (Bishop, Duncan, & Lawrence, 
2004). Thus, trait-anxiety should be considered as co-variate when examining 
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threat-related stimuli for example in fear conditioning paradigm or in the trauma 
film paradigm. 
2.1.2 Physiological risk factors of PTSD 
Aside from psychological factors, potential physiological factors include 
dysregulation of the HPA-axis (e.g., DiGangi et al., 2013; Schmidt, Kaltwasser, & 
Wotjak, 2013), which will be discussed in greater detail in the next chapter (2.1.3.) 
and other abnormalities in psychophysiological measures observed in PTSD patients 
(Pole, 2007). For example, elevated catecholamine levels are found in PTSD patients 
(Wingenfeld, Whooley, Neylan, Otte, & Cohen, 2015), indicating an increased 
sympathetic activity of the autonomous nervous system and mainly associated with 
symptoms of hyperarousal and re-experiencing (O’donnell, Hegadoren, & Coupland, 
2004). Accordingly, patients with PTSD show increased physiological responses if 
confronted with trauma memories (for a review, see Pole, 2007), as evidenced by 
heart rate (e.g., Bedi & Arora, 2007; Orr et al., 1997), skin conductance response 
(Liberzon, Abelson, Flagel, Raz, & Young, 1999) and blood pressure (Bedi & Arora, 
2007). Furthermore, conditioning studies have found that patients with PTSD 
exhibit failed habituation as demonstrated by persistent autonomic responding to 
reappearing and more or less irrelevant sensory cues (Lissek & van Meurs, 2015; 
Pole et al., 2009). This failure to habituate is associated with the hyper-arousal 
symptoms as well as hyper-excitability in PTSD (Lissek & van Meurs, 2015). 
In addition, it is assumed that PTSD patients’ exhibit heightened conditionability 
since they have an overly strong acquisition memory and an insufficiently strong 
extinction memory (Lissek & Grillon, 2012). One possibility assessing individual 
conditionability is given with physiological measures for example the use of HR. In 
particular the pattern of HR might be a fruitful variable to test individual differences 
in fear learning (Hamm & Vaitl, 1996; López, Poy, Pastor, Segarra, & Moltó, 2009; 
Sevenster, Hamm, Beckers, & Kindt, 2015). Since there is evidence that accelerators 
(participants with an increased HR to the CS+ compared to the CS-, in contrast to 
decelerators (participants with a decreased HR to the CS+ compared to the CS-), 
exhibited a higher differential conditioning of the startle response and evaluated 
the CS+ as less pleasant (Hamm & Vaitl, 1996). 
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In the context of cortisol influences on conditioning processes it might be beneficial 
to examine if cortisol would have different effects on differently pronounced 
conditioning processes, i.e., participants who are more conditionable would benefit 
more or even less from cortisol administration. Further, high conditionability and a 
resistance to extinguish fear might be a restraint of the therapy process and should 
be taken into account if trying to improve treatment. 
Altogether, further investigation of psychological as well of psychophysiological risk 
factors and specific continuously altered mechanisms regarding trauma and fear 
memories and in order to influence therapy processes should be performed not 
only to detect predisposing factors, but also to individualize treatment options. 
2.2 The stress response in PTSD 
Characteristics of the stress response of the HPA axis are discussed as a potential 
source of vulnerability to trauma-related psychopathology as it is noticeably altered 
in PTSD (e.g., Yehuda, 2002). There are several studies linking PTSD to an altered 
regulation of the HPA axis: unusual patterns of stress response with low basal 
(unstimulated) cortisol levels, enhanced HPA feedback function, a progressive 
sensitization of the HPA axis and raised catecholamine levels were found in 
individuals with PTSD (e.g., Morris, Compas, & Garber, 2012; Wingenfeld et al., 
2015; Yehuda, 2002; Zoladz & Diamond, 2013). It is important to note, however, 
that these findings of an altered HPA axis are not consistent, as some studies 
showed no association between PTSD diagnoses and altered HPA axis functioning 
(Klaassens, Giltay, Cuijpers, van Veen, & Zitman, 2012; Miller, Chen, & Zhou, 2007). 
The inconsistency of these results may be attributable to the measurement of basal 
cortisol activity since cortisol may vary depending on used methods and time points 
of measurement (Morris et al., 2012). There are various methods available to assess 
cortisol activity including samples of blood, saliva, urine, cerebrospinal fluid and hair 
(Hellhammer, Wust, & Kudielka, 2009; Morris et al., 2012; Stalder & Kirschbaum, 
2012). Each method has specific advantages and disadvantages, capturing unique 
temporal foci of diurnal HPA functioning. As already stated in chapter 3, cortisol 
concentration fluctuates in a circadian rhythm, with high values in the morning, low 
values in the evening and is further influenced by level of stress (Karow & Lang-
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Roth, 2012). Thus, to take analysis by saliva as an example, cortisol activity must be 
strictly controlled for certain influencing factors, such as the already mentioned 
time of day or, also, a previous food intake. It would be interesting to examine if 
patterns could be recognized here, e.g., are certain methods associated with the 
absence of an effect. 
Nevertheless, since associations between PTSD and altered HPA functions have 
been found, the question arises, whether the low cortisol levels in PTSD patients 
may be enabling the beneficial effects of cortisol on PTSD symptoms. In response, it 
is necessary to draw attention to the well-established memory modulating effects 
of GCs in various studies using healthy participants with normal basal cortisol levels 
(see also chapter I, section 3) (for a review, see Het et al., 2005). Moreover, our own 
results of study 2, which included only healthy participants, nicely demonstrated an 
enhanced consolidation effect of cortisol on extinction learning. Therefore, 
dysregulation of the HPA axis does not constitute a prerequisite for the impact of 
cortisol on memory processes. 
2.2.1 The role of the corticosteroid receptors 
Another aspect that might influence the effects of GC on memory processes is the 
type of receptor. GCs mediate their effects by binding to two subtypes of 
intracellular receptors, the GR and the MR (de Kloet et al., 2011). These two 
receptors are homogenous in their structure and represented throughout the brain, 
but differ in their affinity to GCs (see also chapter I, section 3). While GR have a 
rather low affinity to GCs compared to MR, they are receptors mainly stimulated in 
response to stress (de Kloet et al., 2011). As already described, corticosteroid 
receptors modulate several cognitive processes, including memory processes. Most 
of the effects associated with GCs, especially in the context of stress, have been 
attributed to GR, but the importance of MR has also been pointed out (for a review, 
see Reul et al., 2000). For example, there are findings indicating an opposing role of 
MRs and GRs in memory retrieval, while blocking MR impaired memory retrieval in 
humans especially for emotional pictures, blocking GR improved free recall of 
neutral and emotional pictures (Rimmele, Besedovsky, Lange, & Born, 2013). 
Another study found that emotional empathy was enhanced through stimulation of 
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the MR via fludrocortisone in healthy participants and women with borderline 
personality disorder (Wingenfeld et al., 2014). So far, studies on the memory 
modulating influences of the MR or on the interplay of both receptor types are 
scare (Rimmele et al., 2013; Wingenfeld & Wolf, 2015) and further studies are 
necessary to understand the complex interplay of GR and MR (Wingenfeld & Wolf, 
2015). 
2.3 The role of successful treatment sessions 
As already mentioned in previous sections it is important when using cortisol in 
combination with psychotherapy, to ensure a successful therapy session since 
cortisol can also have possibly negative and non-beneficial learning effects by 
improving consolidation and reconsolidation processes of unsuccessful therapy 
sessions. To illustrate this complex matter, an experimental study also using the 
trauma film paradigm in healthy subjects found that intrusions were increased 
instead of decreased in response to a "traumatic" film in subjects who had elevated 
endogenous cortisol levels after a memory reactivation challenge by a cold pressor 
test (Cheung, Garber, & Bryant, 2015). Thus, the current practice of giving cortisol 
prior to exposure contains the risk that the consolidation of an unsuccessful session 
might be promoted by cortisol, but the findings of study 2 offers a new opportunity. 
They showed that administering cortisol after extinction learning facilities the 
consolidation of it as it strengthens extinction memory. This is of high clinical 
relevance as it would allow evaluating the treatment session first and then 
administering cortisol and thereby, circumvent the risk of promoting an 
“unsuccessful” therapy session. However, it has to be noted that criteria and the 
assessment for “success” of treatment sessions are still under debate. Common 
ways to evaluate treatment success are based on standardized questionnaires (e.g., 
for PTSD IES-R) at the beginning and end of a session and/or self-assessment 
questionnaires as participants or patients report fear ratings, symptom load or 
anxiety levels prior to and after a session. Furthermore, the evaluation, in particular 
in the clinical context is also based on a clinical judgment of the therapist. 
Physiological measurements (e.g., HR, SCL or Startle) commonly used in research to 
assess for example the strength of fear extinction, but they are not so widespread in 
the clinical practice. 
I V  G e n e r a l  Discussion  | 81 
 
3. LIMITATIONS, STRENGTHS AND DIRECTIONS FOR FUTURE RESEARCH 
Some limitations of the current thesis must be taken into account. The use of 
experimental analogue paradigms for investigating trauma/fear memory processes 
in healthy participants has limitations, as watching traumatic film clips is not 
comparable with a real-life traumatic event. However, as already mentioned above 
(see chapter I, section 4), controlled paradigms in healthy individuals are useful 
experimental additions to clinical research, and for some questions they are even 
inevitable (Ehring & Ehlers, 2011). They allow circumvention of problems that are 
created by real-life assessment, such as assessing pre- and peri-traumatic factors in 
order to investigate the development and persistence of PTSD. In exchange, the 
obtained results might not be fully transferable to patients. 
Overall generalizability of the results may be restricted because, due to ethical 
reasons, only healthy participants without any psychopathology or prior traumatic 
experiences were included in both studies. Furthermore, participation was limited 
to subjects between 18 and 35 years old. Previous studies have observed changes in 
the response to cortisol treatment not only with psychiatric diseases but also with 
age (e.g., Lupien et al., 1994; Wolf et al., 2001). This could be due at least in some 
extent to differences in basal cortisol activity of menstruating and postmenstrual 
women as findings indicate that the menstrual cycle modulates the relation 
between cortisol and memory (Andreano, Arjomandi, & Cahill, 2008). Thus, in the 
future, studies examining cortisol administration should also consider investigating 
the effects in order of aging. 
In addition, in study 1 only female participant were included, whereas study 2 
included both male and female participants. In both studies only female 
participants taking hormonal contraceptives were included due to pragmatic 
reasons: studies are more complex and require greater control to account for stage 
of menstrual cycle if free-cycling women are included. Thus in a first step, there is a 
need to investigate whether cortisol effects differ by gender in PTSD therapy, as it is 
evident that the effects of cortisol on memory processes in general  differ between 
men and women (for a review see Sandi, 2013; Sauro et al., 2003). In addition, 
cortisol effects on emotional learning and memory differ dependent on the 
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menstrual cycle in free-cycling women (Andreano et al., 2008; Kirschbaum, 
Kudielka, Gaab, Schommer, & Hellhammer, 1999) and additionally cortisol influence 
on emotional memory formation differ between free-cycling women and women 
taking hormonal contraceptives (Merz et al., 2012; Nielsen et al., 2015). Therefore, 
in a second step, women who do not use hormonal contraceptives should be 
investigated, as it has been shown that sex hormones also have an impact on the 
formation of intrusive memories, e.g., high salivary estragon level concentration in 
women is associated with increased frequency of intrusive memories (Ferree et al., 
2011). Moreover, sex hormones have been shown to influence conditioning 
processes, in particular fear extinction, in healthy humans of both genders (Milad et 
al., 2006; Milad et al., 2010). 
After all, it should be a long-term goal of research to more sufficient represents the 
complexity of PTSD in order to investigate how treatment may be enhanced. Since 
probably a large number of factors complexly interact with each other and up to 
date research only allows a fragmentarily examination. 
However, one noteworthy methodological strength of this work was performing 
randomized, double-blind and placebo-controlled studies, the gold standard in 
intervention-based studies (Misra, 2012). This allowed us to control for confounding 
variables and eliminated the possibility of expectation effects occurring as masking 
was first dissolved at completion of data analysis. 
4. CONCLUSION 
To summarize, two experimental analogue studies in healthy participants, 
addressing the dual effect of cortisol on emotional memory processes (1) 
demonstrated that repeated cortisol administration in the aftermath of a traumatic 
event had no impact on experimentally-induced trauma memories, i.e., cortisol did 
not inhibit retrieval of intrusive memories or lower recognition performance for 
trauma-related material, but (2) emphasized the role of cortisol regarding long-term 
consolidation processes, as it strengthened extinction memory, i.e., cortisol 
administered immediately after extinction learning facilitated the storage of 
corrective experiences (extinction memory) indicated by a reduced ROF on the 
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following day. To conclude, the findings of the current thesis shed a bit of light on 
the underlying memory mechanism responsible for the beneficial effects of cortisol 
in combination exposure therapy. Specifically, one can at least conclude that the 
enhancing effect of GCs on consolidation plays a critical role in a lower fear 
response. Thus, transferred to the clinical studies combining cortisol administration 
and exposure therapy would imply that one crucial mechanism of the beneficial 
effect of cortisol relies on the enhancing GCs effect on consolidation of the therapy 
sessions. Another benefit from administering cortisol after a treatment session 
would be to circumvent the risk of promoting the consolidation of an unsuccessful 
treatment session. Whether GCs have also an impairing effect on trauma and fear 
memories or whether a combination of both proposed mechanisms (inhibiting the 
retrieval of trauma/fear memories, facilitating consolidation of extinction learning) 
may also contribute to improved treatment remains open and needs to be 
examined in further experimental as well as clinical studies. Thus, it would be 
inaccurate to state, “cortisol is a pharmacological booster to enhance treatment for 
PTSD”. 
In sum, the results of this thesis showed that cortisol should not be used as sole 
treatment option in PTSD, but that it should be considered for use as a 
pharmacological treatment adjunct to trauma-focused therapies, in particular after 
successful treatment sessions. 
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VI ANNOTATIONS 
This doctoral thesis is based on two experiments, which are submitted or in 
preparation for publication as ‘Original Articles’ in international peer-reviewed 
journals. I am the first author of the articles, but other authors contributed to the 
work and are listed below. Both articles are presented here in their original form 
apart from changes in formatting (e.g., figures and labeling). 
Chapter II 
Graebener, A.H., Michael, T., Holz, E., Lass-Hennemann, J., (2017, in press). 
Repeated cortisol administration does not reduce intrusive memories – a double 
blind placebo controlled experimental study. Manuscript submitted for publication. 
European Neuropsychopharmacology. doi: 10.1016/j.euroneuro.2017.09.001  
Chapter III 
Graebener, A.H., Lass-Hennemann, J., Wilhelm, F., Michael, T. (in preparation). 
Cortisol adminstration prevents the return of fear in a novel fear conditioning 
paradigm with traumatic film clips. 
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